Skip Navigation Links Home   |   Hybrid poster area   |   Poster presentations  

Poster Presentations

At a glance:





Poster Session: Clinical Cases - Kidney - Surgical

P-001     INCARCERATED SMALL BOWEL THROUGH A RENAL PARATRANSPLANT HERNIA AFTER KIDNEY TRANSPLANTATION

Eneida Bra, Naim Fakih, Iago Justo, Oscar Caso, Maria Garcia, Sergio Olivares, Alejandro Manrique, Felix Cambra, Jorge Calvo, Enrique Moreno, and Carlos Jimenez; Madrid, Spain

 

P-002     RENAL TRANSPLANTATION WITH ARTERIAL INFLOW FROM AN AXILLO-FEMORAL GRAFT

Jodie H. Frost, U. Mathuram Thiagarajan, Atul Bagul, and Michael L. Nicholson; Leicester, United Kingdom

 

P-003     MANAGING EARLY SURGICAL COMPLICATIONS BY KIDNEY GRAFT REPERFUSION WITH A COLD STORAGE SOLUTION

Libor Janousek, and Michal Kudla; Prague, Czech Republic

 

P-004     ULCUS CRURIS DUE TO PSEUDALLESCHERIA BOYDII INFECTION AFTER RENAL TRANSPLANTATION – A RARE DIFFERENTIAL DIAGNOSIS IN A COMMON LESION

Martin Jazra, Peter Schenker, Claudia Hempel, Andreas Wunsch, Christian Altenhenne, Agnes Anders, and Richard Viebahn; Bochum, Germany; and Herne, Germany

 

P-005     FIBROMUSCULAR DYSPLASIA WITH RENAL ARTERY ANEURYSM: DILEMMA OF AUTOTRANSPLANTATION

Avneesh Kumar, and Ahmed Halawa; Sheffield, United Kingdom

 

P-006     POST-BIOPSY RENAL ALLOGRAFT COMPARTMENT SYNDROME

Umasankar Mathuram Thiyagarajan, Ismail Mohamed, Atul Bagul, and Michael L. Nicholson; Leicester, United Kingdom

 

P-007     SURGICAL AND MEDICAL CHALLENGES WITH KIDNEY TRANSPLANTATION IN VACTERL ASSCOCIATION. CASE REPORT

Gabor Telkes, Gyorgy Reusz, Attila Szabo, Marina Varga, and Robert Langer; Budapest, Hungary

 

P-008     REGULAR ULTRASONOGRAPHY IN AUTOTRANSPLANTED KIDNEY – EARLY DIAGNOSIS OF ASYMPTOMATIC OBSTRUCTIVE UROPATHY

Hsu-Han Wang, Yang-Jen Chiang, Kuan-Lin Liu, Kuo-Jen Lin, and Sheng-Hsien Chu; Linkou, Taiwan

 

P-009     IMMUNOSUPPRANT RELATED NEUROTOXICITY AFTER ABO-INCOMPTIBALE KIDNEY TRANSPLANTATION

Chi-Chuan Yeh, Ching-Yao Yang, Wei-Chou Wu, and Meng-Kun Tsai; Taipei, Taiwan


Poster Session: Clinical Cases - Kidney - Medical

P-010     THE CHALLENGE OF TREATING POLYOMA VIRUS ASSOCIATED NEPHROPATHY

Christina Dörje, Anna Varberg Reisæter, Tommy Aronsen, Erik H. Strøm, and Karsten Midtvedt; Oslo, Norway

 

P-011     TREATMENT OF HYPERURICEMIA-GOUT ATTACTS AFTER RENAL TRANSPLANTATION WITH CONVERSION TO EVEROLIMUS MONOTHERAPY

Pedro Errasti, Francisco Javier Lavilla, and Asuncion Ferrer; Pamplona, Spain

 

P-012     SUCCESSFUL TREATMENT OF REFRACTORY BK VIRUS NEPHROPATHY WITH WEANING ALL IMMUNOSUPPRESSION BUT PREDNISONE – A CASE REPORT

Barbara Grandtnerova, Nadezda Mäcková, and Katarina Machalekova; Martin, Slovakia; and Banska Bystrica, Slovakia

 

P-013     URETERIC STRICTURE IN RENAL ALLOGRAFT – TO REIMPLANT OR NOT?

Vincent C.W. Wong, Norella C.T. Kong, G.A. Halim, M. Rozita, C.A. Rizna, and Jasitha Thevarajah; Cheras, Malaysia

 

P-014     KIDNEY GRAFT VENOUS ANASTOMOTIC STENOSIS: AN UNUSUAL CAUSE OF REVERSIBLE PRIMARY NON GRAFT FUNCTION

Eva Languille, Leïla Tricot, Gaëlle Pellé, Christian Hiesse, Anne Kolko-Labadens, Alain Raynaud, and Michel Delahousse; Suresnes, France; and Paris, France

 

P-015     SUCCESSFUL TREATMENT OF PULMONARY MUCORMYCOSIS WITH DESFERASIROX-POSACONAZOLE-AMPHOTERICIN B AFTER KIDNEY TRANSPLANTATION: A CASE REPORT

Nuttasith Larpparisuth, Suchai Sritippawan, Angkana Chaiprasert, Nalinee Premasathian, Attapong Vongwivatana, Somkiat Vasuvattakul, Rujipas Sirijatuphat, and Methee Chayakulkeeree; Bangkok, Thailand

 

P-016     METASTATIC SARCOMATOID CARCINOMA TO LIVER AND BONE MARROW IN RENAL TRANSPLANT RECIPIENT: DUE TO EXACERVATION OF QUIESCENT RENAL CANCER?

Hyun Hee Lee, Jae Hyun Jang, and Yeon Ho Park; Incheon, Republic of Korea

 

P-017     EBV LYNPHOPROLIFIRATIVE SYNDROME A CHILD KIDNEY TRANSPLANTATION

Sihem Oussalah, Lynda Badaoui, Rabia Chafai, and Atmane Seba; Tizi Ouzou, Algeria

 

P-018     VISCERAL LEISHMANIOUSIS IN A CHILD TRANSPLANTED KIDNEY

Sihem Oussalah, Lynda Badaoui, Rabia Chafai, and Atmane Seba; Tizi Ouzou, Algeria

 

P-019     ANAESTHESIA FOR KIDNEY TRANPLANTATION IN A PATIENT WITH PRADER WILLI SYNDROME

Catherine J. Atkinson, Karunakaran Ramaswamy, and Sabeena Sharma; Oxford, United Kingdom

 

P-020     HEADACHES ONE YEAR AFTER RENAL TRANSPLANTATION

Simon Rau, Lousia von Baumgarten, Antje Habicht, Bruno Meiser, Michael Fischereder, and Ulf Schönermarck; Munich, Germany

 

P-021     PRE- TRANSPLANT HbA1c LEVEL IS AN EARLY PREDICTIVE MARKER FOR NEW-ONSET DIABETES MELLITUS IN RENAL TRASPLANT RECIPIENTS

Erhan Tatar, Meltem Sezis Demirci, Ozkan Gungor, Fatih Kircelli, Gulay Asci, Mehmet Ozkahya, Ercan OK, Cuneyt Hoscoskun, and Huseyin Töz; Izmir, Turkey

 

 P-022     LATE ACUTE RENAL DYSFUNCTION: A CHALLENGE DIAGNOSIS

Francesca Tinti, Luca Poli, Ilaria Umbro, Paola Cinti, Pasquale B. Berloco, and Anna Paola Mitterhofer; Rome, Italy

 

P-023     HOW MANY TIMES CAN PARVOVIRUS B19-RELATED ANEMIA RECURE IN SOLID-ORGAN TRANSPLANT RECIPIENT?

Clément Gosset, Denis Viglietti, Corinne Antoine, Fabiane Rocha, Samuel Cavalcante, Denis Glotz, and Evangéline Pillebout; Paris, France

 

Poster Session: Clinical Cases - Pancreas - Medical

P-024     RARE CASE OF URETERAL OBSTRUCTION IN A RENAL TRANSPLANT RECIPIENT: Candida albicans FUNGUS BALL

Naoko Arichi, Yozo Mitsui, Keita Inoue, Chiaki Kobara, Takeo Hiraoka, Masahiro Sumura, Satoshi Honda, Hiroaki Yasumoto, Hiroaki Shiina, and Mikio Igawa; Izumo, Japan

 

P-025     ACUTE INFLAMMATORY SYNDROME INDUCED BY MYCOPHENOLATE MOFETIL IN A PATIENT FOLLOWING PANCREAS TRANSPLANTATION

Jun Li, Paolo Girotti, Nils Heyne, Ingmar Königsrainer, Ruth Ladurner, Alfred Königsrainer, and Silvio Nadalin; Tübingen, Germany

Poster Session: Clinical Cases - Liver - Surgical

P-026     RECONTRUCTION OF THE HEPATIC OUTFLOW OF A AMYLOID HEPATIC ALLOGRAFT (AHA) FROM A PATIENT RECEIVING A COMBINED HEART LIVER TRANSPLANTATION – A CASE REPORT

Christoph Anthoni, Hartmut H.J. Schmidt, Norbert Senninger, Hans H. Scheld, T.D.T. Tjan, Klaus Hahnenkamp, and Heiner Wolters; Münster, Germany

 

P-027     EARLY OCCURRENCE OF KAPOSI’S SARCOMA IN POST TRANSPLANT PATIENT TREATED SUCCESSFULLY WITH EVEROLIMUS

Kamran Beydullayev, Rauf Shahbazov, Rena Bilalova, Elnur Faracov, Hasan Isayev, Shahnaz Cafarova, Alovsat Isayev, Shahin Osmanov, Eldar Ahmedov, and Mircelal Kazimi; Baku, Azerbaijan

 

P-028     TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPSS) IN A CHILD TRANSPLANTED WITH A LEFT LATERAL SEGMENT FROM A SPLIT LIVER GRAFT

Vittorio Corno, MariaClara Dezza, Roberto Nani, Roberto Agazzi, Paola Stroppa, Michela Bravi, and Michele Colledan; Bergamo, Italy

 

P-029     TRIPLE LIVER TRANSPLANTATION FOR RECURRENT AUTOIMMUNE HEPATITIS INITIALLY MASQUERADING AS FULMINANT WILSON’S DISEASE

Alexander Kroemer, Axel Doenecke, Andreas Schnitzbauer, Gabi Kirchner, Stefan Farkas, Martin Loss, Edward K. Geissler, Marcus Scherer, and Hans J. Schlitt; Regensburg, Germany

 

P-030     A RARE CAUSE OF ACUTE LIVER FAILURE: ADULT ONSET STILL’S DISEASE – CASE REPORT AND SYSTEMATIC REVIEW OF THE LITERATURE

Juliane Liese, Frank Ulrich, Teresa Schreckenbach, Matthias Wahle, Stefan Zeuzem, Wolf Otto Bechstein, and Christian Moench; Frankfurt, Germany

 

P-031     LIVER TRANSPLANTATION IN A PATIENT WITH AN INTRAABDOMINALLY LOCATED LEFT VENTRICULAR ASSIST DEVICE

Nicolas Meurisse, Nina Vermeer, Koen Ameloot, Diethard Monbaliu, Mark De Laat, Dirk Vlasselaers, Lars Desmet, David Cassiman, Bart Meyns, and Jacques Pirenne; Leuven, Belgium

 

P-032     DIAPHRAGM RUPTURE IN A LIVER TRANSPLANT PATIENT UNDER CHRONIC IMMUNOSUPPRESSIVE THERAPY WITH SIROLIMUS. CLINICAL CASE

Anna Rossetto, Umberto Baccarani, Gian Luigi Adani, Vittorio Bresadola, Giovanni Terrosu, Dario Lorenzin, and Dino De Anna; Udine, Italy

 

P-033     DOES LATE RECURRENCE AFTER HEPATECTOMY FOR HCC IMPACT ON SURVIVAL AFTER LIVER TRANSPLANTATION FOR HCC RECURRENCE? A CASE REPORT

Gonzalo Sapisochin, Cristina Dopazo, Roberto Rodriguez, Francesc Espin, Luis Castells, Mireia Caralt, Jose Luis Lazaro, Itxarone Bilbao, and Ramon Charco; Barcelona, Spain

 

P-034     IS SORAFENIB A NEW TESSERA IN THE MOSAIC OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA BEFORE LIVER TRANSPLANTATION?

Giuseppe Tarantino, Fabrizio Di Benedetto, Giuseppe D’Amico, Nicola De Ruvo, Nicola Cautero, Roberto Montalti, Gian Piero Guerrini, Roberto Ballarin, Rosa M. Iemmolo, and Giorgio E. Gerunda; Modena, Italy

 

P-035     LIVER TRANSPLANTATION AFTER THREE-WEEK HEPATIC COMA

Toomas Väli, Kadri Tamme, Andres Tein, and Silver Sarapuu; Tartu, Estonia


Poster Session: Clinical Cases - Liver - Medical

               

P-036     WITHDRAW

 

P-037     TRANSIENT IMPROVEMENT OF ACQUIRED HEPATOCEREBRAL DEGENERATION IN A PATIENT WITH HCV CIRRHOSIS AFTER LIVER TRANSPLANTATION: A CASE REPORT AND REVIEW OF LITERATURE

Yuanyuan Chen, Mazhar Haque, Andrew Woolfenden, and Eric Yoshida; Vancouver, Canada

 

P-038     POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AFTER LIVER TRANSPLANTATION

Oscar Caso, Naim Fakih, Iago Justo, Alejandro Manrique, Jorge Calvo, Alvaro Garcia, Felix Cambra, Manuel Abradelo, Enrique Moreno, and Carlos Jimenez; Madrid, Spain

 

P-039     ANTIBODY-MEDIATED CHRONIC REJECTION REVERSED BY B-CELL DEPLETING AGENT IN A LIVER RETRANSPLANT RECIPIENT

Cheng-Maw Ho, Yao-Ming Wu, Ming-Chih Ho, Rey-Heng Hu, and Po-Huang Lee; Taipei, Taiwan

 

P-040     HEMOSUCCUS PANCREATICUS (HP) AFTER LIVER TRANSPLANTATION (LT)

Anna Mrzljak, Karlo Novacic, Nikola Sobocan, Miroslava Katicic, Dinko Škegro, and Branislav Kocman; Zagreb, Croatia

 

Poster Session: Clinical Cases - Cardiothoracic - Surgical

               

P-041     DIMENSION COUNTS: AN UNUSUAL CASE OF BLEEDING AFTER CENTRIFUGAL LVAD IMPLANTATION

Gianluca Santise, Sergio Sciacca, Marco A. Turrisi, Vincenzo Stringi, Robert L. Kormos, and Michele Pilato; Palermo, Italy; and Pittsburgh, USA

 

Poster Session: Islet / Cell transplant

P-042     CYTOPROTECTIVE EFFECT OF HUMAN ADIPOSE TISSUE DERIVED REGENERATIVE CELL ON PORCINE ISLET CELLS

Michihito Asanoma, Mitsuo Shimada, Toru Utunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Syuichi Iwahashi, Yu Saito, and Shinichiro Yamada; Tokushima, Japan

 

P-043     IMPROVED THE EFFECT OF ISLET TRANSPLANTATION BY ENDOTHELIAL CELLS COATING AND INFUSION SERTOLI CELLS

Yang Li, Wujun Xue, Xiaohui Tian, Xiaoming Ding, Xinshun Feng, Puxun Tian, Jun Hou, Xiaoming Pan, Hang Yan, Heli Xiang, Chenguang Ding, and Shengbin Li; Xi’an, China

 

P-044     SEARCHING FOR KERATINOCYTE SPORE-STEM CELLS

Waldemar L. Olszewski, Anna Domaszewska-Szostek, Marzanna Zaleska, and Beata Szymanska; Warsaw, Poland

 

P-045     GLYCATED ALBUMIN IMPAIRS GLUCOSE-INDUCED INSULIN SECRETION IN RAT PANCREATIC ?-CELLS

Tokihiko Sawada, Takayuki Shiraki, Yoshikazu Miura, KyungHwa Park, Takashi Muto, and Keiichi Kubota; Tochigi, Japan

 

P-046     INVASION AND HOMING EFFICIENCY OF INTRAVENOUS INJECTED MARROW MESENCHYMAL CELLS IN INFARCTED MYOCARDIUM RATS MODEL

Zhenya Shen, and Yulong Hou; Suzhou, China

 

P-047     THE EXPERIMENTAL STUDY OF AUTOLOGOUS MESENCHYMAL STEM CELLS MOBILIZATION INHIBIT VENTRICULAR REMODELING AFTER ACUTE MYOCARDIAL INFARCTION

Zhenya Shen, and Peng Deng; Suzhou, China

 

Poster Session: Composite tissues

P-048     VASCULARIZED BONE MARROW TRANSPLANTATION MODEL IN RATS AS AN ALTERNATIVE TO CONVENTIONAL CELLULAR BONE MARROW TRANSPLANTATION – PRELIMINARY RESULTS

Dragos Zamfirescu, Ioan Lascar, Ion Zegrea, Marius Popescu, Corina Popoviciu, Anca Lupu, Maya Simionescu, and Marco Lanzetta; Bucharest, Romania; Monza, Italy; and Canberra, Australia

 

Poster Session: Allocation

P-049     OLD AND NEW INSIGHTS IN THE EVALUATION OF MARGINAL KIDNEY DONORS: A MONOCENTRIC EXPERIENCE

Maria Messina, Ester Gallo, Antonio Lavacca, Valentina Borretta, Elisabetta Mezza, Michela Tamagnone, and Giuseppe Paolo Segoloni; Turin, Italy

 

 P-050     KIDNEY TRANSPLANTATION FROM LIVING DONORS IN NORTHERN PORTUGAL

Bruno A. Lima, and Helena Alves; Porto, Portugal

Poster Session: Ethics, Law, Psychosocial, Public Policy


P-052     “I HAD NO END OF PEOPLE TELLING ME NOT TO DO IT”: SOCIAL AND PSYCHOLOGICAL PROCESSES IN NON-DIRECTED KIDNEY DONATION- A GROUNDED THEORY APPROACH

Alexis Clarke, and Annie Mitchell; Plymouth, United Kingdom

 

P-053              BARRIERS FOR IMMUNOSUPPRESSIVE MEDICATION-TAKING DIFFER AMONG ADULT KIDNEY, LIVER AND HEART TRANSPLANT RECIPIENTS

Kristel Van de loock, Lut Berben, Sandra Engberg, Susan Sereika, Fabienne Dobbels, Johan Vanhaecke, Kris Denhaerynck, Gabriela Schmid-Mohler, Sandra Martin, Juri Ducci, Paulo De Simone, Rudolf Wüthrich, and Sabina De Geest; Leuven, Belgium; Basel, Switzerland; Pittsburgh, USA; Zürich, Switzerland; and Pisa, Italy

 

P-054     EDHEP, EUROPEAN DONOR HOSPITAL EDUCATION PROGRAM: A SWEDISH PERSPECTIVE

Peter Desatnik; Lund, Sweden; and Helsingborg, Sweden

 

P-055     AN ETHICAL ANALYSIS OF THE ROMANIAN DEBATES ON PRESUMED CONSENT

Mihaela Frunza, Cristina Gavriluta, Beatrice-Gabriela Ioan, and Sandu Frunza; Iasi, Romania; and Cluj, Romania

 

P-056     THE EFFORT TO ENLIGHTEN ABOUT LOCAL CITIZEN ORGAN DONATION ? TRANSPLANTATION TOGETHER WITH TRANSPLANT PATIENT SOCIETY

Masae Ikeda, Kazunari Yoshida, Daisuke Ishii, Kenji Yamamoto, Seiichi Tatematsu, Fumino Noguchi, Tadao Endo, Tadasu Sakai, and Shiro Baba; Sagamihara, Japan

 

P-057     QUALITY OF LIFE AFTER KIDNEY TRANSPLANTATION (LIVING NON-RELATED REGULATED PROGRAM)

Rose Marie R. Liquete, Ma. Lourdes C. Garcia, Wenceslao Agnir, and Pedro L. Mejia IV; Quezon City, Philippines

 

P-058     THE HIPPOCRATIC OATH IN THE STUDY OF THE MEDICAL ETHICS OF THE LIVING DONOR HEMI-PANCREATECTOMY

Constantinos S. Mammas, George Kottis, Nikolaos Arkadopoulos, Georgia Kostopanagiotou, and Vasileios Smyrniotis; Milan, Italy; and Athens, Greece

 

P-059     BARRIERS TO LIVING DONATION: A QUALITATIVE STUDY OF RECIPIENT ANXIETIES

Sabrina Qureshi, Nizam Mamode, and John Weinman; London, United Kingdom

 

P-060     SELF-REGULATORY FACTORS AND MEDICATION ADHERENCE AFTER KIDNEY TRANSPLANTATION: FINDINGS AT 6 WEEKS POST-TRANSPLANT

Emma K. Massey, Mirjam Tielen, Mirjam Laging, Teun van Gelder, and Willem Weimar; Rotterdam, The Netherlands

 

 P-061     SOURCES OF ORGAN TRANSPLANTS IN CHINA

David Matas; Winnipeg, Canada

 

P-062     ASSESSMENT OF ANXIETY AND DEPRESSION IN KIDNEY TRANSPLANT PATIENTS

Daniel Merino, Cecilia Buljevich, Paola Siezien, Andrea Cosmai, Ruben Schiavelli, and Roberto Sabbatiello; Buenos Aires, Argentina

 

P-063     WHEN MEDIA CAMPAIGNS FAIL – MISCONCEPTIONS ABOUT ORGAN DONATION AND TRANSPLANTATION AMONG THE RURAL MALAY COMMUNITY IN MALAYSIA

and Selvarani P. Kovil Pillai; Sydney, Australia

 

 P-064     TERMS AND SIGNIFICANCE IN TRANSPLANTATION MEDICINE

Paola Parente, Maria Luisa Di Pietro, Antonio G. Spagnolo, and Barbara Corsano; Rome, Italy

 

P-065     THE DEFINITION OF QUALITY OF LIFE IN SOLID ORGAN TRANSPLANTATION: A PSYCHOLOGICAL QUALITATIVE MODEL

Chantal Piot-Ziegler, John David Aubert, Manuel Pascual, and Iris 8A Team Health Psychology; Lausanne, Switzerland

 

 P-066     IS THE TRANSLANTATION ETHICS AT THE CROSSROAD?

Wojciech A. Rowinski, and Leszek Paczek; Warsaw, Poland

 

 P-067     EXPLORING THE ROLE AND RELATIONSHIP BETWEEN THE GIFT, DECEASED ORGAN DONATION AND RELIGION: A CASE STUDY OF POLISH IMMIGRANTS

Chloe Sharp, Gurch Randhawa, and Kulwinder Kaur-Bola; Luton, United Kingdom

 

P-068     THE MISTAKE OF COMMUNICATION WITH RELATIVES OF HEART-BEATING DONORS: VIDEO MODEL

Anikó Smudla, Sándor Mihály, Katalin Hegedüs, and János Fazakas; Budapest, Hungary

 

P-069     ATTITUDE TOWARDS XENOTRANSPLANTATION OF PATIENTS PRIOR AND AFTER HUMAN ORGAN TRANSPLANTATION

Philipp Stiegler, Michael Sereinigg, Andreas Puntschart, Vanessa Stadlbauer-Köllner, Steve Müller, Karlheinz Tscheliessnigg, and Wolfgang Freidl; Graz, Austria

 

 P-070     Skype SAVED THE ELPAT CONGRESS

Marian van Noord-Haubrich, Frederike Ambagtsheer, Annalisa Ponchia, Chiara Parisotto, Judith Kal-van Gestel, Willij Zuidema, and Willem Weimar; Rotterdam, The Netherlands; and Padua, Italy

 

P-071     TO IMPROVE LOW ORGAN DONATION RATE AMONG ETHNIC MINORITY GROUPS IN UNITED KINGDOM

Yanmei Wei; London, United Kingdom         

 

Poster Session: Clinical immunosuppression

P-073     ATG MODE OF ACTION: T-CELL DEPLETION AND FAR BEYOND

Dietmar K. Abendroth, Michael Marzinzig, and Juergen KJaden; Ulm, Germany; and Berlin, Germany

 

P-074     IMPACT OF MDR1 AND CYP3A5 GENETIC POLYMORPHISMS ON TACROLIMUS DOSAGE REQUERIMENTS AND ACUTE REJECTION IN CAUCASIAN LIVER TRANSPLANT RECIPIENTS

Jose Mº. Alamo, Miguel A. Gomez-Bravo, Merce Brunet, Magdalena Salcedo, Constantino Fondevilla, Francisco Suarez, Jose Castellote, Sebastian Rufian, Jose A. Pons, Itxarone Bilbao, Elisabet Torrademé, and Lydia Barrera; Sevilla, Spain; Barcelona, Spain; Madrid, Spain; A. Coruña, Spain; Cordoba, Spain; and Murcia, Spain

 

P-075     IN-VITRO ASSESSMENT OF T CELL RESPONSE AND CLINICAL STATUS OF TRANSPLANT PATIENTS ON VARIOUS IMMUNOSUPPRESSIVE DRUGS IN KwaZulu-Natal (SOUTH-AFRICA)

Alain G. Assounga, and Saleha Omarjee; Durban, South Africa

 

P-076     CORRELATION OF EVEROLIMUS EXPOSURE WITH EFFICACY AND SAFETY OUTCOMES IN RENAL TRANSPLANT RECIPIENTS: 24-MONTH UPDATE

M. Carmellini, M. Yaqoob, J. Pattison, H. Riad, Z. Wang, C. Cornu-Artis, and H. Tedesco Silva; Siena, Italy; London, United Kingdom; Manchester, United Kingdom; East Hanover, USA; Basel, Switzerland; and Sao Paulo, Brazil

 

P-077     THYMOGLOBULINE PRE-TREATMENT AND MINIMIZATION OF IMMUNOSUPPRESSION WITH ADVAGRAF IN LIVER TRANSPLANTATION ALLOWS INCREASE OF Treg AND GUIDANCE OF TOLEROGENESIS. PRELIMINARY RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL

Nicola De Ruvo, Giovanni Riva, Fabrizio Di Benedetto, Giuseppe Tarantino, Patrizia Barozzi, Leonardo Potenza, Mario Luppi, and Giorgio E. Gerunda; Modena, Italy

 

P-078     PRELIMINARY RESULTS OF GENERIC MYCOPHENOLATE MOFETIL (Myfenax) TREATMENT IN DE NOVO RENAL TRANSPLANT RECIPIENTS

Alicja Debska-Slizien, Beata Bzoma, Boleslaw Rutkowski, and Andrzej Chamienia; Gdansk, Poland

 

P-079     CONVERSION FROM TWICE-DAILY TACROLIMUS (Prograf®) TO ONCE-DAILY PROLONGED RELEASE TACROLIMUS (Advagraf®) IN LIVER TRANSPLANT RECIPIENTS

Massimo Del Gaudio, Matteo Cescon, Giorgio Ercolani, Alessandro Cucchetti, Matteo Zanello, Alessandro Dazzi, Augusto Lauro, Matteo Ravaioli, Cristina Morelli, and Antonio Daniele Pinna; Bologna, Italy

 

P-080              RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES

Antoine Durrbach, Franco Citterio, Laura Mulloy, Elias David-Neto, Graeme Russ, Sefan Vitko, Rubin Zhang, Jun Xing, Mary Beth Harler, and Josep Grinyo; Kremlin Bicêtre, France; Rome, Italy; Augusta, USA; Sao Paulo, Brazil; Adelaide, Australia; Praha, Czech Republic; New Orleans, USA; Hopewell, USA; Princeton, USA; and Barcelona, Spain

 

P-081     CLINICAL OUTCOME IN HEART TRANSPLANT RECIPIENTS RECEIVING TACROLIMUS RETARD (Advagraf®)

Uwe Fuchs, Armin Zittermann, Bernd Schulze, Kavous Hakim-Meibodi, Uwe Schulz, and Jan Gummert; Bad Oeynhausen, Germany

 

P-082     IMPACT OF CHANGE TO A PRIMARY IMMUNOSUPPRESSION REGIMEN OF BASILIXIMAB, MYCOPHENOLATE, PREDNISOLONE AND LOW-DOSE TACROLIMUS, ON THE 3 YEAR OUTCOME OF KIDNEY TRANSPLANTATION

Matthew Casey, Marc Clancy, Ray Wan, Manolis Mazonakis, and Colin C. Geddes; Glasgow, United Kingdom

 

P-083              IMPROVING OR SUSTAINING RENAL FUNCTION OVER 3 YEARS WITH BELATACEPT OR CYCLOSPORINE A (CsA): INSIGHTS FROM THE BENEFIT STUDY

Josep Grinyo, Marwan Abouljoud, Michael Germain, Roberto Manfro, José Morales, Christophe Legendre, Chen-Sheng Lin, Mamta Agarwal, and José Medina Pestana; Barcelona, Spain; Detroit, USA; Springfield, USA; Rio Grande do Sul, Brazil; Madrid, Spain; Paris, France; Princeton, USA; and São Paulo, Brazil

 

P-084     EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION

Markus Guba, Johann Pratschke, Christian Hugo, Bernhard K. Kraemer, Andreas Pascher, Katharina Pressmar, Oliver Hakenberg, Michael Fischereder, Jens Brockmann, Joachim Andrassy, Manfred Stangl, Banas Bernhard, and Karl-Walter Jauch; Munich, Germany; Innsbruck, Austria; Dresden, Germany; Mannheim, Germany; Berlin, Germany; Erlangen, Germany; Rostock, Germany; Zurich, Switzerland; and Regensburg, Germany

 

P-085     SIROLIMUS RESCUE THERAPY AFTER ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTS – ONE YEAR FOLLOW UP

Medhat M.A. Halim, Torki Al-Otaibi, K.V. Johny, Mohamed H. Hamid, Osama Gheith, Hany Adel, Ahmed Musaad, Tarek Said, Prasad Nair, and M.R.N. Nampoory; Kuwait, Kuwait

 

P-086     EVALUATING EFFICACY AND SAFETY OF TWO IMMUNOSUPPRESSIVE REGIMENS IN KIDNEY TRANSPLANT PATIENTS – THREE YEARS RESULTS

Milan Kuman, Vladimir Mejzlik, Pavel Studenik, Jiri Ondrasek, and Petr Nemec; Brno, Czech Republic

 

P-087              INTENSIFIED DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM ACHIEVES EARLY HIGH DRUG EXPOSURE AND LOWER RATES OF ACUTE REJECTION VERSUS STANDARD DOSING IN DE NOVO RENAL TRANSPLANT RECIPIENTS

D. Kuypers, H. Tedesco Silva, K. Budde, W. Arns, A. Shoker, and H. Prestele; Leuven, Belgium; São Paulo, Brazil; Berlin, Germany; Cologne, Germany; Saskatchewan, Canada; and Basel, Switzerland

 

P-088     EXTENDED-RELEASE TACROLIMUS THERAPY IN DE NOVO CARDIAC TRANSPLANT RECIPIENTS: SINGLE-CENTER EXPERIENCE

Jose Luis Lambert Rodriguez, Beatriz Diaz-Molina, Maria Jose Bernardo Rodriguez, Maria Martin Fernandez, Juan Carlos Llosa Cortina, and Carlos Morales; Oviedo,  Spain

 

P-089     BASILIXIMAB INDUCTION CAN TRIGGER SHOCK AND ARDS IN YOUNG RECIPIENTS

Annick Massart, Sarah Heenen, Gilbert Bejjani, Hoang D. Anh, Dimitri Mikhalski, Emine Broeders, Daniel De Backer, and Daniel Abramowicz; Brussels, Belgium

 

P-090     EVALUATING THE IMPACT OF GASTROINTESTINAL EPISODES ON THE HEALTH-RELATED QUALITY OF LIFE OF SOLID ORGAN TRANSPLANT RECIPIENTS: SENSITIVITY TO CHANGE OF THE SIGIT-QoL QUESTIONNAIRE. MYPACIENTE-2 STUDY

F. Ortega, J.M. Puig, F.J. Paúl-Ramos, M.M. Salcedo, J.A. Bravo, J. De la Cruz, R. Lauzurica, M. Miras, G. Rodríguez-Goyanes, and the Mypaciente-2 Study Group; Oviedo, Spain; Barcelona, Spain; Zaragoza, Spain; Madrid, Spain; Granada, Spain; Malaga, Spain; Badalona, Spain; El Palmar, Murcia, Spain; and Vigo, Spain

 

P-091     EXTENDED RELEASE TACROLIMUS VERSUS CONVENTIONAL TACROLIMUS IN DE NOVO ORTHOTOPIC LIVER TRANSPLANTATION

Jorge Ortiz de Urbina-Lopez, Jose Ramón Fernandez Ramos, Amaia Matarranz Sanz, Andres Valdivieso Lopez, Francisco Javier Bustamante Schneide, Mikel Gastaca Mateo, Milagros Testillano Tarrero, P. Ruiz ordorica, Alberto Ventoso Castiñeiro, Javier Gonzalez Uriarte, and MJ Suarez Regueiro; Barakaldo, Spain

 

P-092     ORAL STATUS OF RENAL TRANSPLANT RECIPIENTS RECEIVING CYCLOSPORIN A OR TACROLIMUS

Otília Pereira-Lopes, Benedita Sampaio-Maia, Susana Sampaio, Pedro Vieira-Marques, Maria Ferreira, Elsa Lopes, Filipa Silva, Manuel Pestana, and António Felino; Porto, Portugal

 

P-093     IMPACT OF ONCE-DAILY PROLONGED-RELEASE TACROLIMUS ON HCV-SPECIFIC IMMUNE RESPONSE OF PATIENTS UNDERWENT OLTx COMPARED TO TWICE A DAY TACROLIMUS TREATMENT

Alessandro Perrella, Donatella Pisaniello, and Oreste Cuomo; Naples, Italy

 

P-094     IMPACT OF ONCE-DAILY PROLONGED-RELEASE TACROLIMUS ON HCV-SPECIFIC IMMUNE RESPONSE  OF PATIENTS UNDERWENT OLTx COMPARED TO TWICE A DAY TACROLIMUS TREATMENT

Alessandro Perrella, Donatella Pisaniello, Walter Santaniello, Luca Campanella, and Oreste Cuomo; Naples, Italy

 

P-095     ANTIBODY-BASED IMMUNOSUPPRESSIVE THERAPY AND IMMUNE RESPONSE TO DECEASED DONOR’S KIDNEY ALLOGRAFT: A SINGLE CENTRE EXPERIENCE

Tatjana Rainiene, Rasa Dobrovolskiene, Nina Izvolskaja, Balys Dainys, Arunas Zelvys, Loreta Vareikiene, and Kestutis Strupas; Vilnius, Lithuania

 

P-096     MANAGEMENT OF MODERATE TO SEVERE CHRONIC RENAL GRAFT DYSFUNCTION USING mTOR: LONG-TERM RESULTS

Suzimar S. Rioja, Joan Oliveira, Marcelo Bernardino, Adriana D´Angeles, Sérgio R.M. Souza, Albanita V. Oliveira, and Lilimar S. Rioja; Rio de Janeiro, Brazil

 

P-097     PHARMACOKINETICS OF EVEROLIMUS WHEN COMBINED WITH TACROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS

L. Rostaing, J. Pascual, U. Machein, and J.M. Kovarik; Toulouse, France; Barcelona, Spain; and Basel, Switzerland

 

P-098     DEVELOPMENT OF ANTI-HLA ANTIBODIES AFTER CONVERSION TO AN mTOR INHIBITOR IN STABLE RENAL TRANSPLANT PATIENTS

Estrella Quintela, Juan C. Ruiz, Jose M. Pastor, David San Segundo, Emilio Rodrigo, Maria Gago, Marcos Lopez-Hoyos, and Manuel Arias; Santander, Spain

 

P-099     USEFULNES AND SAFETY OF mTOR IN LIVER TRASPLANTATION

Gloria Sanchez Antolin, Felix García-Pajares, Carolina Almohalla, Judith Gil Dominguez, Sara Lorenzo Pelayo, Lorena Sancho, Rafael Ruiz Zorrilla, and Agustin Caro Paton; Valladolid, Spain

 

P-100              EVEROLIMUS AS PRIMARY IMMUNOSUPPRESSION IN KIDNEY TRANSPLANTATION: EXPERIENCE IN CONVERSION FROM CALCINEURIN INHIBITORS

Ana I. Sanchez-Fructuoso, Juan C. Ruiz, Natividad Calvo, Emilio Rodrigo, Isabel Pérez-Flores, Carlos Gomez-Alamillo, Manuel Arias, and Alberto Barrientos; Madrid, Spain; and Santander, Spain

 

                P-101     DIFFERENTIAL EFFECTS OF CALCINEURIN INHIBITORS ON ARTERIAL FUNCTION

Felix Seibert, Carolin Behrendt, Sven Schmidt, Walter Zidek, Markus van der Giet, and Timm H. Westhoff; Berlin, Germany

 

                P-102     PREDICTABLE PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD), AND EXPOSURE-RESPONSE (E-R) OF BELATACEPT AVOID THE NEED OF THERAPEUTIC DRUG MONITORING (TDM)

Jinshan Shen, Zexun Zhou, Robert Townsend, and Sanjeev Kaul; Princeton, USA

 

                P-103     RATIONALE FOR BELATACEPT LESS-INTENSIVE (LI) REGIMEN IN RENAL TRANSPLANT RECIPIENTS

Jinshan Shen, Jeff S. Gelb, Robert M. Townsend, Zexun Zhou, Marc Pfister, Mary Beth Harler, and Sanjeev Kaul; Princeton, USA

 

                P-104     COMPARISON OF THE SIDE EFFECTS OF DE NOVO MPAs IN FIRST 3 MONTHS AFTER KIDNEY TRANSPLANTATION: SINGLE CENTER EXPERIENCE

Hakan Sozen, Utku Yilmaz, Kibriya Fidan, Galip Gur, Ulver Verici, Sukru Sindel, and Aydin Dalgic; Ankara, Turkey

 

                P-105     EFFECT OF EARLY CONVERSION FROM CALCINEURIN INHIBITORS TO EVEROLIMUS ON RENAL FUNCTION AND MARKERS OF CARDIOVASCULAR DISEASE: DESIGN OF THE ELEVATE STUDY

M. van der Giet, J.W. de Fijter, H. Holdaas, C. Legendre, U. Machein, G. Junge, and J.M. Cruzado; Berlin, Germany; Leiden, Netherlands; Oslo, Norway; Paris, France; Basel, Switzerland; and Barcelona, Spain

 

                P-106     TACROLIMUS SIDE EFFECTS AFTER LIVER TRANSPLANTATION: IS THERE A DIFFERENCE BETWEEN ONCE DAILY AND TWICE DAILY FORMULATION?

Nina Weiler, Ina Thrun, Marion Eberlin, Irene Kraemer, and Gerd Otto; Mainz, Germany

 

                P-107     SPECIALIST PHARMACIST ROLE IN HIV-POSITIVE RENAL TRANSPLANTATION

Hayley Wells, Lucy Galloway, Martin Drage, and Rachel Hilton; London, United Kingdom

 

                P-108     IMMUNOSUPPRESSION IN HCV-RNA POSITIVE LIVER TRANSPLANT RECIPIENTS

Ekaterina B. Yaroshenko, Maxim N. Kornilov, Igor A. Miloserdov, and Yan G. Moysyuk; Moscow, Russian Federation

 

                P-109     PHARMACOKINETICS AND CLINICAL OUTCOMES OF DE NOVO RENAL TRANSPLANTATION WITH ONCE-DAILY TACROLIMUS EXTENDED RELEASE(TER)

Kazunari Yoshida, Jun Tomizawa, Daisuke Ishii, Masahiro Kobayashi, Yasuo Takeuchi, Haruki Wakai, Fumino Noguchi, Masae Ikea, Kazuo Yago, and Shiro Baba; Sagamihara, Japan

 

Poster Session: Pre-Clinical immunosuppression

                P-110     EFFECT OF CYCLOSPORINE A ADMINISTRATION IN PREGNANT RATS ON BLOOD PRESSURE IN THEIR OFFSPRING

Natalia Slabiak-Blaz, Marcin Adamczak, Eberhard Ritz, and Andrzej Wiecek; Katowice, Poland; and Heidelberg, Germany

 

                P-111     BELATACEPT 6-MONTH INTRAVENOUS TOXICITY STUDY IN MONKEYS

Helen G. Haggerty; New Brunswick, USA

 

                P-112     ANTI-CLASS II HUMANIZED ANTIBODY, IMMU-114 SUCCESSFULLY SUPPRESSES ALLOGENEIC IMMUNE RESPONSE

KyungHwa Park, Tokihiko Sawada, Toru Murakami, Yasuo Ishii, Mineko Yasuo, Shohei Fuchinoue, and Keiichi Kubota; Tochigi, Japan; and Tokyo, Japan

 

                P-113     THE REVERSIBLE REDUCTION OF ?-CELL ADAPTABILITY INDUCED BY mTOR INHIBITION IN AN EXPERIMENTAL RAT MODEL

Jordi Rovira, Barbara Vodenik, Belén Nadal, Maria J. Ramírez-Bajo, Elisenda J. Bañón-Maneus, Daniel Moya-Rull, Anna Novials, Fritz Diekmann, and Josep M. Campistol; Barcelona, Spain

 

                P-114     ATG-Fresenius INHIBITS EBV INFECTION OF HUMAN B-CELLS  IN VITRO

Reinhard Zeidler, Judith Atz, and Isabell Seitz-Merwald; Munich, Germany; and Graefelfing, Germany

 

Poster Session: Histocompatibility

                P-115     GENETICS DETERMINES LONG OR SHORT-TERM KIDNEY SURVIVAL. RARE CLASS I HLA ALLELES FOUND BY SEQUENCE BASED TYPING

Helena Alves, Sandra Tafulo, Manuel Dias, Filomena Mendes, Maria Peixoto, Susana Oliveira, and Manuela Monteiro; Porto, Portugal

 

                P-116     PREDICTIONS IN THE FACE OF CLINICAL REALITY: T-CELL EPITOPE CLASSIFICATION OF HLA-DPB1 MISMATCHES DOES NOT PREDICT SEVERE ACUTE GvHD

Medhat Askar, Jesse Schold, Jaroslaw Maciejewski, Robert Dean, Hien Duong, Rabi Hanna, Matt Kalaycio, Edward Copelan, Brian Bolwell, and Ronald Sobecks; OH, USA

 

                P-117     DE NOVO BUT NOT PREFORMED DONOR-SPECIFIC ANTI-HUMAN LEUKOCYTE ANTIGEN ANTIBODIES ARE PREDICTIVE OF SURVIVAL AFTER LUNG TRANSPLANTATION

Agnès Basire, Anaïs Rousset, Caroline Bouchet, Kassim Papa, Coralie Frassati, Pascal Thomas, Martine Reynaud-Gaubert, and Christophe Picard; Marseille, France

 

                MC900354038[1]P-118              COMPARING LUMINEX-DEFINED HLA ANTIBODIES WITH FLOW CYTOMETRIC CROSSMATCHES IN RENAL TRANSPLANT PATIENTS

Raymond Fernando, Joyce Grant, Aliyye Karasu, Graham D. Shirling, Gita Turakhia, Rachel Wilson, and Henry A.F. Stephens; London, United Kingdom

 

                P-119     HLA MATCHING REDUCES THE INCIDENCE OF EARLY RENAL TRANSPLANT FAILURE IN SENSITISED PATIENTS

Susan V. Fuggle, Rachel J. Johnson, Lisa Mumford, Alex Hudson, and J.A. Bradley; Bristol, United Kingdom; and Cambridge, United Kingdom

 

                P-120     ABO INCOMPATIBLE KIDNEY TRANSPLANTATION WITH CAMPATH INDUCTION

Michael M. Kaabak, Nadezda N. Babenko, Alan K. Zokoyev, Emin L. Salimov, and Aligeydar A. Ragymov; Moscow, Russian Federation

 

                P-121     ANALYSIS OF KIR GENE PROFILES IN RENAL TRANSPLANT RECIPIENTS

Aliyye Karasu, Graham D. Shirling, Mark Harber, and Henry A.F. Stephens; London, United Kingdom

 

                P-122     NO EVIDENCE FOR INVOLVEMENT OF DONOR OR RECIPIENT NK-CELL ALLOREACTIVITY IN LIVER TRANSPLANTATION OUTCOME

Viviana Moroso, Arnold van der Meer, Geert Kazemier, Luc J.W. van der Laan, Herold J. Metselaar, Irma Joosten, and Jaap Kwekkeboom; Rotterdam, The Netherlands; and Nijmegen, The Netherlands

 

                P-123     POSITIVE LUMINEX IN CADAVERIC RENAL TRANSPLANTATION AND ITS EARLY PREDICTABILITY OF GRAFT FUNCTION, REJECTION EPISODES

Umasankar Mathuram Thiyagarajan, Atul Bagul, Terry Horsburgh, and Michael L. Nicholson; Leicester, United Kingdom

 

                P-124     HLA-DQ AND -DP ALPHA/BETA CHAIN ANTIBODIES IN RENAL TRANSPLANTATION

Antonina Piazza, Elvira Poggi, Giuseppina Ozzella, Daniela Caputo, Giuseppe Iaria, Giuseppe Tisone, and Domenico Adorno; Rome, Italy

 

                P-125     THE ROLE OF HLA IN CYTOTOXIC T-CELL IMMUNOTHERAPY OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE

Victoria J. Robertson, Emily Thompson, Paul Dunn, Lorraine Syme, David M. Turner, Marc L. Turner, Gwen M. Wilkie, David Wilson, and Philip A. Dyer; Edinburgh, United Kingdom; Auckland, New Zealand; and Aberdeen, United Kingdom

 

                P-126     ARE ADDITIONAL ANTIBODIES DETECTED BY LUMINEX SINGLE ANTIGEN TESTING CLINICALLY RELEVANT?

Caner Süsal, Khaled Mahmoud, Jörg Ovens, Bernd Döhler, Andrea Ruhenstroth, Sabine Scherer, and Gerhard Opelz; Heidelberg, Germany

 

                P-127     HLA MATCHING BASED ON BOTH NUMBER AND TYPE OF MISMATCHES CORRELATES BETTER WITH GRAFT OUTCOMES IN DECEASED-DONOR KIDNEY TRANSPLANTATION (DDKT)

Francisco Salcido-Ochoa, N. Yusof, C.Y. Phang, H.C. Wong, Y.H. Chan, Y.M. Lu, M. Chan, and T. Kee; Singapore, Singapore

 

                P-128     SOLUBLE CD30 AND HEPATOCYTE GROWTH FACTOR AS PREDICTIVE MARKERS OF ANTIBODY-MEDIATED REJECTION OF THE KIDNEY ALLOGRAFT

Yelena Pavlova, Ondrej Viklicky, Janka Slatinska, Marcela Bürgelova, Caner Susal, Ilja Striz, and Antonij Slavcev; Prague, Czech Republic; and Heidelberg, Germany

 

                P-129     ACUTE MEDIATED REJECTION AFTER A KIDNEY TRANSPLANT WITH PREFORMED anti-HLA ANTIBODIES ABOVE THE LEVEL DESCRIBED TO HAVE CLINICAL SIGNIFICANCE: CASE REPORT

Sandra Tafulo, Cecília Mendes, Manuela Monteiro, Manuela Bustorff, Gerardo Oliveira, and Helena Alves; Porto, Portugal

 

Poster Session: Immunobiology / Basic science

                P-130     ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE T-786C POLYMORPHISM IN RENAL TRANSPLANT RECIPIENTS

Negar Azarpira, Saman Nikeghbalian, Mahdokht Aghdai, Bita Geramizadeh, Masumeh Darai, Marjan Rahsaz, Mehrzad Banihashemi, and Zahra Malekpor; Shiraz, Islamic Republic of Iran

 

                P-131     RAPAMYCIN MAY ALTER THE PERCENTAGE OF THE Treg FOXP3 AND/OR GITR POSITIVE IN ENVIRONMENT OF THE CALCINEURIN INHIBITORS

Katarzyna Bocian, Maja Budziszewska, Tomasz Paz, and Grazyna Korczak-Kowalska; Warsaw, Poland

 

                P-132     DIFFERENTIATION OF DENDRITIC CELLS IN IMMUNOSUPPRESSIVE AGENTS IN VITRO

Maja Machcinska, Katarzyna Bocian, and Grazyna Korczak-Kowalska; Warsaw, Poland

                MC900354038[1]P-133              INTERFERON GAMMA PROMOTES STARVATION-INDUCED AUTOPHAGY BY ACTIVATING THE GCN2-ATF4 PATHWAY

Sophie Fougeray, Christophe Legendre, Dany Anglicheau, Eric Thervet, and Nicolas Pallet; Paris, France

 

                P-134     IDENTIFICATION OF A NOVEL MICA ALLELE MICA*002:04 BY SEQUENCING BASED TYPING AND CLONE SEQUENCING

Yingfeng Huang, Yin Tan, and Xin Ye; Guangzhou, China

 

                P-135     IL28B GENE POLYMORPHISM FOR PREDICTION OF EARLY VIROLOGICAL RESPONSE IN ROMANIAN PATIENTS WITH RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION

Speranta Iacob, Razvan Iacob, Anca Nastase, Daniel Coriu, Liliana Paslaru, Irinel Popescu, and Liana Gheorghe; Bucharest, Romania

 

                P-136     Tokishakuyaku-san PROLONGED SUrVIVAL OF FULLY ALLOGENEIC CARDIAC GRAFTS AND GENERATED REGULATORY CD4+ CELLS IN MICE

Xiangyuan Jin, Masateru Uchiyama, Qi Zhang, and Masanori Niimi; Tokyo, Japan; and Harbin, China

 

                P-137     HUMAN B CELL DEVELOPMENT AND ANTIBODY PRODUCTION IN HUMANIZED NOD/SCID/IL-2R?null (NSG) MICE CONDITIONED BY BUSULFAN

Bongkum Choi, Miyoung Kim, Milljae Shin, Sanghyun Song, Hyung Hwan Moon, Sanghoon Lee, Tae-Seok Kim, Ki-Young Lee, and Sung Joo Kim; Seoul, Republic of Korea; and Suwon, Republic of Korea

 

                P-138     COMPARISON OF ERYTHROCYTE MEMBRANE FATTY ACID CONTENTS AND LIPID PROFILES IN RENAL TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS

Joon Seok Oh, Sung Min Kim, Yong Hun Sin, Joong Kyung Kim, Young Ki Son, Won Suk Ahn, Seong Eun Kim, and Ki Hyun Kim; Dong-gu, Busan, Korea; and Busan, Korea

 

                P-139     AN EX VIVO MODEL FOR ASSESSMENT OF ALTERED LUNG FUNCTION DURING LUNG TRANSPLANTATION

Sara Klein, Stefan Dhein, Luisa Bauer, Marcel Vollroth, Maja-Theraesa Dieterlen, Friedrich W. Mohr, and Hartmuth B. Bittner; Leipzig, Germany

 

                P-140     TCR-INDEPENDENT EXPANSION OF FOXp3+CD4+ REGULATORY T CELLS BY CD137 STIMULATION

Hong R. Cho, Jong S. Lee, Juyang Kim, Hyun C. Chung, Wonyoung Kim, and Byungsuk Kwon; Ulsan, Korea

 

                P-141     TRYPTOPHAN CATABOLITES AS PROGNOSTIC BIOMARKERS FOR THE SEVERITY OF CHRONIC LIVER DISEASES IN POTENTIAL TRANSPLANT RECIPIENTS

Imad Lahdou, Hani Oweira, Mahmoud Sadeghi, Volker Daniel, Gerhard Fusch, Jeorg C. Schefold, Gregor Jung, Hazem Elhadedy, Jan Schmidt, Mircea Iancu, Gerhard Opelz, and Peter Terness; Heidelberg, Germany; Greifswald, Germany; and Berlin, Germany

 

                P-142     DONOR PRETREATMENT WITH ANTI-IL-6 DOES NOT REDUCE INFLAMMATORY ACUTE PHASE PROTEINS IN A RAT BRAIN DEATH MODEL

Bo Liu, Jeffery Dammen, Petra J. Ottens, Susanne Veldhuis, Rutger J. Ploeg, and Henri G.D. Leuvenink; Groningen, The Netherlands

 

                P-143     HLA POSITIVITY BY LUMINEX CROSSMATCH AND ITS EARLY EFFECTS IN LIVE DONOR RENAL TRANSPLANTATION

Umasankar Mathuram Thiyagarajan, Atul Bagul, Terry Horsburgh, and Michael L. Nicholson; Leicester, United Kingdom

 

                P-144     OPTIMIZING LIVER DECELLULARIZATION FOR ORGAN ENGINEERING

Reiichi Murakami, H. Abraham Chiang, John Roberts, and Sang-Mo Kang; San Francisco,  USA

 

                P-145     RESPONSES TO NON-POLYMORPHIC HLA CLASS 1 DERIVED PEPTIDES ARE MEDIATED BY CD4+ T EFFECTOR MEMORY CELLS

Helen J. Smith, Seema Jham, Paul Cockwell, Richard Borrows, and Simon Ball; Birmingham, United Kingdom

 

                P-146     CONVERSION TO ONCE-DAILY TACROLIMUS IN RENAL TRANSPLANT RECIPIENTS LEADS TO HIGHER P38 MAPK ACTIVITY IN T LYMPHOCYTES

Ramin Vafadari, Dennis A. Hesselink, Teun van Gelder, Willem Weimar, and Carla C. Baan; Rotterdam, The Netherlands

 

                P-147     MANNOSE RECEPTOR DEFICIENCY PROTECTS MICE FROM ISCHEMIC-REPERFUSION INJURY AND NEPHROTOXIC NEPHRITIS

Hsu-Han Wang, Alan D. Salama, Sally Hamour, Ruth Pepper, and Mark Little; London, United Kingdom

 

                P-148     CCR1 AND CCR3 EXPRESSION IN FINE-NEEDLE ASPIRATION BIOPSY SAMPLES FROM KIDNEY TRANSPLANTS

Paula D.P. Xavier, Susana S. Norton, Sérgio Gaião, Helena Alves, and José G.G. Oliveira; Porto, Portugal

Poster Session: Heart

                P-149     PLACENTA GROWTH FACTOR AS A MARKER OF CARDIAC ALLOGRAFT VASCULOPATHY SEVERITY IN HEART TRANSPLANT RECIPIENTS

Olga P. Shevchenko, Olga V. Orlova, Boris L. Mironkov, Eduard N. Kazakov, Arkady J. Kormer, and Alex O. Shevchenko; Moscow, Russian Federation

 

                P-150     PROFILE OF HEART TRANSPLANT RECIPIENT WITH DYSLIPIDEMIA IN THE ERA OF THE UNIVERSAL USE OF STATINS – CROSS-SECTIONAL STUDY

Michael Zakliczynski, Julia Boguslawska, Edyta Wojniak, and Marian Zembala; Zabrze, Poland

 

                P-151     DTCM-GLUTARIMIDE SUPPRESSES IFN-? AND AMELIORATES CARDIAC ALLOGRAFT ARTERIOSCLEROSIS IN MICE

Masaaki Zaitsu, Kenichiro Yamashita, Susumu Shibasaki, Yusuke Tsunetoshi, Masaomi Ogura, Tadashi Yoshida, Kenji Wakayama, Gentaro Hirokata, Rumi Igarashi, Nozomi Kobayashi, Michitaka Ozaki, Kazuo Umezawa, and Satoru Todo; Sapporo, Japan; and Yokohama, Japan

 

                P-152     IS ATRIAL SYNCHRONY BENEFICIAL IN HEART TRANSPLANTED PATIENTS?

Cristina F. Sirbu, Marie F. Mattei, and Jean-Pierre Villemot; Nancy, France

 

                P-153     HEART TRANSPLANTATION IS FEASIBLE IN PATIENTS WITH IMPAIRED RENAL FUNCTION

Oscar Kolsrud, Sven-Erik Ricksten, Villborg Sigurdardottir, Ulf Kjellman, Hans Liden, Sven-Erik Bartfay, Nedim Selimovic, and Göran Dellgren; Gothenburg, Sweden

 

                P-154     HEART DONATION AND TRANSPLANTATION IN SAUDI ARABIA

Faissal A.M. Shaheen, Besher A. Al-Attar, Abdulqayoum Babiker, Johny E. Cillo, and Michael V. Abeleda; Riyadh, Saudi Arabia

 

                P-155     IMMUNOSUPPRESSIVE THERAPY IN LONG TERM HEART TRANSPLANTS: 5 YEAR SURVEY ON 56 PATIENTS WITH MORE THAN 10 YEAR FOLLOW-UP

Cristiano Amarelli, Mariano Cefarelli, Marianna Buonocore, Claudio Marra, Daniela Pinto, Gianpaolo Romano, Luca S. De Santo, and Ciro Maiello; Naples, Italy; and Foggia, Italy

 

                P-156     “NON WORKING BEATING HEART” A NOVEL METHOD OF MYOCARDIAL PROTECTION DURING HEART TRANSPLANTATION

Jarbas Jakson Dinkhuysen, Carlos Contreras, Reginaldo Cipullo, Marco Aurélio Finger, João Rossi, Ricardo Manrique, Hélio Magalhães, and Paulo Chaccur; São Paulo, Brazil

 

                P-157     EVALUATION OF EFFICACY AND SAFETY OF DE NOVO ADVAGRAF IN CARDIAC TRANSPLANT PATIENTS: EARLY RESULTS OF AN OBSERVATIONAL STUDY

Farsad E. Eskandary, Arezu Z. Aliabadi, Stephane Mahr, Martina Grömmer, Daniel Zimpfer, Sigrid E. Sandner, Günther Laufer, and Andreas O. Zuckermann; Vienna, Austria

 

                P-158     CLUSTER TRANSPLANTATION FOR SHORT BOWEL SYNDROME DUE TO COMBINED THROMBOSIS OF THE SUPERIOR MESENTERIC ARTERY AND CELIAC TRUNK

Oscar Caso, Iago Justo, Naim Fakih, Sergio Olivares, Jorge Calvo, Felix Cambra, Manuel Abradelo, Alejandro Manrique, Alvaro Garcia, Enrique Moreno, and Carlos Jimenez; Madrid, Spain

 

                P-159     ROLE OF HCV POSITIVE DONORS IN HEART TRANSPLANTATION

Alberto Forni, Giuseppe Faggian, Bartolomeo Chiominto, and Alessandro Mazzucco; Verona, Italy

 

                P-160     IMMUNOSUPPRESSION AND RENAL FAILURE (RF) IN HEART TRANSPLANTATION: 3 YEARS EXPERIENCE

Francesco Marchini, Andrea Bortolami, Giuseppe Toscano, Antonio Gambino, Cosimo Guglielmi, Barbara Rossi, Giuseppe Feltrin, Gino Gerosa, and Agostino Naso; Padua, Italy

 

                P-161     QT INTERVAL PARAMETERS ALTERNATION IN PATIENTS RECEIVED RENAL TRANSPLANTATION

Ali Monfared, Arsalan Salari, Farshad Asadi, Mohammadkazem Lebadi, Masoud Khosravi, and Sepiedeh Besharati; Rasht, Guilan, Islamic Republic of Iran

 

                P-162     PRESERVATION OF DONATION AFTER CARDIAC DEATH HEARTS USING OXYGENATED, HYPOTHERMIC MACHINE PERFUSION

Omar A. Mownah, Muhammad A. Khurram, Christopher Ray, Joaquim Majo, Noel M. Carter, John Brassil, Robert Peaston, Kelly Phillipson, Susan Stamp, John H. Dark, and David Talbot; Newcastle upon Tyne, United Kingdom; and Sunderland, United Kingdom

 

                P-163     AN EX VIVO MODEL FOR REANIMATING PORCINE HEARTS SOURCED FROM DONORS AFTER CARDIAC DEATH

Muhammad A. Khurram, Omar A. Mownah, Christopher Ray, Aditya Kanwar, Noel M. Carter, John Brassil, Doug Rees, Susan Stamp, John H. Dark, and David Talbot; Newcastle upon Tyne, United Kingdom; and Sunderland, United Kingdom

 

                P-164     THE EXPERIMENTAL STUDY OF INDUCING IMMUNETOLERANCE BY USING  TLR4 MONOCLONAL ANTIBODYS IN TAT CARDIAC ALLOGRAFTS

Zhenya Shen, Xiaomei Teng, and Bing Li; Suzhou, China

 

                P-165     THE METABOLIC SYNDROME ONE YEAR AFTER HEART TRANSPLANTATION DOES NOT AFFECT 10 YEAR SURVIVAL BUT ISCHEMIC HEART DISEASE BEFORE TRANSPLANTATION INCREASES THE RISK OF METABOLIC SYNDROME

Henrik Silfverstolpe, Cecilia Jimhagen, Nedim Selimovic, Göran Dellgren, and Vilborg Sigurdardottir; Gothenburg, Sweden

 

                P-166     THE ROLE OF SERUM ALBUMIN (SA) IN THE PREDICTION OF MALNUTRITION IN PATIENT AT LEAST ONE HEART TRANSPLANTATION (HTX)

Doris Wagner, Barbara Telsnig, Daniela Kniepeiss, Estrella Jakoby, Silvia Schaffellner, Astrid Fahrleitner-Pammer, Andrä Wasler, Regina Roller, and KarlHeinz Tscheliessnigg; Graz, Austria

 

                P-167     INDUCED IMMUNE TOLERANCE TO CARDIAC ALLOGRAFTS BY INTRATHYMIC INOCULATION WITH ALLOGENEIC SPLEEN CELLS AND WHOLE-BODY -RADIATION IN THE PIG

Yunsheng Yu, Zhenya Sheng, Shiying Zheng, Wenxue Ye, and Weijie Lao; Suzhou, China

 

                P-168     INCORPORATION OF THE DONOR DNA IN TO THE RECIPIENT LYMPHOID CELLS AFTER ALLOGENEIC TRANSPLANTATION

Malgorzata Zagozda, Agnieszka Sarnecka, Olga Buyanovskaya, and Waldemar L. Olszewski; Warsaw, Poland

 

                P-169     BOTH HEART FAILURE AND DIABETES INTENSIFY DEPOSITION OF ADVANCED GLYCATION END (AGE) PRODUCTS IN CORONARY VESSELS, BUT LOCALIZATION IS DIFFERENT

Jerzy Nozynski, Michael Zakliczynski, Dominika Konecka-Mrowka, and Marian Zembala; Zabrze, Poland

Poster Session: Donation / Retrieval

                P-170     IS HCV (+) A CONTRAINDICATION TO BE RECIPIENT OF LIVING DONOR?

Iago Justo, Oscar Caso, Sergio Olivares, Naim Fakih, Felix Cambra, Jorge Calvo, Alejandro Manrique, Alvaro García, Manuel Abradelo, Carlos Jimenez, and Enrique Moreno; Madrid, Spain

 

                P-171     HAND ASSISTED RETROPERITONEOSCOPIC LIVE DONOR NEPHRECTOMY – 230 CASES SINGLE CENTRE EXPERIENCE

Jiri Fronek, Helen Gregson, Elisabeth Cording, Maria Ventura, Christina Ho, Caroline Azmy, and Nicos Kessaris; London, Tooting, United Kingdom; London, Surrey, United Kingdom; and Brighton, United Kingdom

 

                P-172     DIFFICULTIES OF ORGAN TRANSPLANTATION COORDINATORS DURING PERFORMING THEIR JOB

Esin Gülkaya, and Fazil Tuncay Aki; Ankara, Turkey

 

                P-173     TRENDS IN THE QUALITY OF KIDNEYS OFFERED AND TRANSPLANTED IN RECENT YEARS. HOW MARGINAL IS A MARGINAL DONOR? ARE MARGINAL DONORS THE NORM? AND WHAT IMPACT THEY HAVE ON RENAL ALLOGRAFT FUNCTIONS? A SINGLE CENTRE ANALYSIS

Abbas Ghazanfar, Maria Mito Pretorian, Aley Bilgarami, David van Dellen, Bence Forgacs, and Afshin Tavakoli; Manchester, United Kingdom

 

                P-174     ANALYSIS OF CONSENT RATES FOR ORGAN DONATION IN THE UK

Jane Griffiths, Cara Murphy, Claire Counter, and Anthony Clarkson; Bristol, United Kingdom

 

                P-175     PROPOSED MODEL FOR PATIENT RESPONSE OUTCOME MEASURES (PROM) IN LIVE DONOR NEPHRECTOMY BASED ON DONOR RESPONSES

Sarah L. Heap, Laura Tincknell, Keith Rigg, Amanda Knight, Alun Williams, and Shantanu Bhattacharjya; Nottingham, United Kingdom

 

                P-176     THE DUTCH TRAINING ‘COMMUNICATION ABOUT DONATION’

Nichon E. Jansen, Bernadette J.J.M. Haase-Kromwijk, Anne-Rose Janssens, and Andries J. Hoitsma; Leiden, The Netherlands; and Nijmegen, The Netherlands

 

                P-177     URINE NGAL AS A BIOMARKER FOR EVALUATION OF DECEASED KIDNEY DONORS

Janis Jushinskis, Diana Amerika, Vadims Suhorukovs, Sergejs Trushkovs, Aleksandrs Maltsevs, and Rafails Rozentals; Riga, Latvia

 

                P-178     CURRENT STATUS OF THE POTENTIAL DECEASED DONOR IN NEUROSURGICAL INTENSIVE CARE UNIT: A MULTI-CENTER EXPERIENCE FROM KOREA

and Samuel Lee; Seoul, Republic of Korea

 

                P-179     A MODEL OF “NON TECHNICAL SKILLS” IN ICU AND ORGAN DONATION

Gaetano Trabucco, Maddalena Marcanti, Marilena Casartelli Liviero, Francesca Allegrini, Sergio Rambaldelli, Rina Mirandola, Giulia Bisoffi, and Francesco Procaccio; Verona, Italy

 

                P-180     FOR KIDNEY TRANSPLANTS, IS IT POSSIBLE TO OFFER NON HEART-BEATING DONORS LOCATED MORE THAN 30 MINS AWAY?

Philippe Michel, and Bruno Gelée; Pontoise, France

 

                P-181     CAUSES OF REJECTION OF POTENTIAL LIVING DONORS FOR LIVING-RELATED LIVER TRANSPLANTATION

Mariana Mihaila, Laurentiu Micu, and Mihai Voiculescu; Bucharest, Romania

 

                P-182     CHANGING RELATIONSHIPS IN KIDNEY DONATION

Geir Mjøen, Torbjørn Leivestad, Ole Øyen, Karsten Midtvedt, Gudrun Norby, and Hallvard Holdaas; Oslo, Norway

 

                MC900354038[1]P-183              LIVING DONOR RENAL TRANSPLANTATION IN DONORS WITH INCIDENTAL NEPHROLITHIASIS

Nilay Patel, Eeke Thomee, Mark Sullivan, John Reynard, Peter Friend, and Sanjay Sinha; Oxford, United Kingdom

 

                P-184     5 YEAR FOLLOW-UP OF INTERNATIONAL CLASSIFICATION OF DISEASES (ICD) BRAIN DEATH RELATED DIAGNOSTICS AT IN-HOSPITAL DISCHARGE, BRAIN DEAD (BD) DETECTED PATIENTS AND BD ORGAN DONORS (OD)

Alba Ribalta, Jorge Twose, Marga Sanromà, and Rosa Deulofeu; Barcelona, Spain

 

                P-185     ESTABLISHING A BRAIN DEATH DONOR MODEL IN PIGS

Michael Sereinigg, Andreas Puntschart, Andrea Bradatsch, Vanessa Stadlbauer-Köllner, Thomas Seifert-Held, Iris Wiederstein-Grasser, Karlheinz Tscheliessnigg, and Philipp Stiegler; Graz, Austria

 

                P-186     ESTABLISHING A NON-HEART-BEATING DONOR (NHBD) MODEL IN PIGS

Philipp Stiegler, Michael Sereinigg, Andreas Puntschart, Martin Schweiger, Ursula Mayhauser, Bettina Leber, Sonja Köstenbauer, Thomas Seifert-Held, Iris Wiederstein-Grasser, and Karlheinz Tscheliessnigg; Graz, Austria

 

                P-187     ORGAN DONATION IN JAPAN: A LONGITUDINAL STUDY OF QUALITY OF LIFE OF LIVING LIVER DONORS

Etsuko Soeda, Minoru Tanabe, Ken Hoshino, Shigeyuki Kawachi, Yasushi Fuchimoto, Hideaki Obara, Masahiro Shinoda, Naoki Shimojima, Yasuhide Morikawa, and Yuko Kitagawa; Tokyo, Japan

 

                P-188     EFFECT OF OXIDATIVE STRESS AND ENDOTOXIN ON HUMAN SERUM ALBUMIN IN BRAIN-DEAD ORGAN DONORS

Philipp Stiegler, Michael Sereinigg, Bettina Leber, Ursula Mayrhauser, Sonja Köstenbauer, Stefanie Stanzer, Andreas Puntschart, Barbara Leopold, Karl Oettl, Karlheinz Tscheliessnigg, and Vanessa Stadlbauer-Köllner; Graz, Austria

 

                P-189     DONOR MANAGEMENT ON LINE: SEVEN YEARS OF REGIONAL EXPERIENCE

Gianfranco Teti, Nicola Torlone, Maurizio Valeri, and Domenico Adorno; Roma, Italy

Poster Session: Infections

                P-190     CLINICAL UTILITY OF A QUANTITATIVE AND FUNCTIONAL FLOW CYTOMETRY ASSAY FOR CMV-SPECIFIC CD8 T CELL IMMUNITY IN TRANSPLANT PATIENTS

Xiangyang Dong, and Roshini S. Abraham; Rochester, USA

 

                P-191     DE NOVO RENAL ALLOGRAFT FEMALE RECIPIENTS, BUT NOT MALE ONES, SHOW INCREASES IN URINARY TRACT INFECTION (UTI) INCIDENCE AND RELAPSES AFTER URETERAL STENTING

Clara Barrios, Marisa Mir, Marta Crespo, Lluis Fumado, Albert Frances, Josep Maria Puig, Juan Pablo Horcajada, Octavio Arango, and Julio Pascual; Barcelona, Spain

 

                P-192     CLINICAL STUDY OF RENAL TRANSPLANTATION IN PATIENTS WITH HEPATITIS C

Xiaoming Ding, Wujun Xue, Puxun Tian, Xiaoming Pan, Hang Yan, Jun Hou, Xinshun Feng, Heli Xiang, Xiaohui Tian, and Yang Li; Xi’an, China

 

                P-193     HEPATIC ABSCESS. A STRANGE COMPLICATION OF OLT

Iago Justo, Sergio Olivares, Felix Cambra, Oscar Caso, Naim Fakih, Jorge Calvo, Alejandro Manrique, Alvaro García, Manuel Abradelo, Carlos Jimenez, and Enrique Moreno; Madrid, Spain

 

                P-194     INFECTIONS IN KIDNEY TRANSPLANTATION: INCIDENCE, TYPE AND LOCATION. A PROSPECTIVE STUDY

F. Fernandez-Rodriguez, J. Fernandez Rodriguez, AM Fernandez-Rodriguez, C. Galeano, R. Marcen, A. Muriel, and C. Quereda; Madrid, Spain

 

                P-195     INDIRECT EFFECTS OF CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS

Takuzo Fujiwara, Shinichiro Tanaka, and Kosuke Ohta; Okayama, Japan

 

                P-196     AGE AND SEX AS RISK FACTORS FOR CMV-INFECTIONS AFTER LUNG TRANSPLANTATION

Bahil Ghanim, Peter Jaksch, Mir Alireza Hoda, Viktoria Augustin, Patrick Nierlich, Axel Scheed, Clemens Aigner, Gyoergy Lang, Shahrokh Taghavi, and Walter Klepetko; Vienna, Austria

 

                P-197     RATE OF URETERIC STRICTURE IS INCREASED IN THE PRESENCE OF BK VIRAEMIA WITHOUT NEPHROPATHY

Marc Gingell-Littlejohn, Hoey Koh, Emanolis Mazonakis, Colin C. Geddes, and Marc J. Clancy; Glasgow, United Kingdom

 

                P-198     DONOR URETER CULTURES IN RENAL TRANSPLANTATION

Petra M. Goldsmith, Sani Aliyu, Andrew J. Bulter, and Paul Gibbs; Cambridge, United Kingdom

 

                P-199     URINARY TRACT INFECTIONS IN RENAL TRANSPLANT RECIPIENTS

Justyna Golebiewska, Alicja Debska-Slizien, and Boleslaw Rutkowski; Gdansk, Poland

 

                P-200     BKV VIREMIA IN A WELL-MATCHED KIDNEY TRANSPLANT POPULATION

Ilkka Helanterä, Kaija Salmela, Lauri Kyllönen, Anne Räisänen-Sokolowski, Laura Mannonen, Eeva Auvinen, Petri Koskinen, and Irmeli Lautenschlager; Helsinki, Finland

 

                P-201     LYMPHOPROLIFERATIVE DISORDER OF THE CENTRAL NERVOUS SYSTEM AFTER RENAL TRANSPLANTATION: SINGLE CENTER EXPERIENCE IN JAPAN

Daisuke Ishii, Kazunari Yoshida, Masae Ikeda, Ryota Maeyama, Kenichi Tabata, Yasuo Takeuchi, Haruki Wakai, Tadao Endo, and Baba Shiro; Sagamihara, Japan

 

                P-202     IMPACT OF RITUXIMAB INDUCTION THERAPY ON CMV INFECTIOUS DISEASE IN ABO INCOMPATIBLE KIDNEY TRANSPLANTATION

Yasuo Ishii, Kazuhiro Iwadoh, Toru Murakami, Kotaro Kai, Ichiro Koyama, Ichiro Nakajima, and Shouhei Fuchinoue; Tokyo, Japan

 

                P-203     INVASIVE MYCOSIS INFECTIONS AMONG KIDNEY TRANSPLANT RECIPIENTS

Maria A. Gini, Sebastian P. Jaurretche, Ana M. Linchenco, Pablo G. Candusso, José L. Sgrosso, and Maria C. Vazquez; Rosario, Argentina

 

                P-204     IL-33 INDUCES DEFENSE MECHANISM AGAINST Candida albicans THROUGH RAPID RECRUITMENT AND ENHANCED FUNCTION OF NEUTROPHILS

Hong R. Cho, Jong S. Lee, Hong-Nga T. Le, Hyun C. Chung, Juyang Kim, and Byungsuk Kwon; Ulsan, Korea

 

                P-205     ISONIAZID PREVENTIVE THERAPY FOR POSTRENAL TRANSPLANT TUBERCULOSIS: A SYSTEMATIC REVIEW

Xianding Wang, Jing Zhuang, Libo Xie, Mingyuan Li, and Yiping Lu; Chengdu, China

 

                P-206     EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC T-CELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS

Elisa S. Pierobon, Lucrezia Furian, Cristina Silvestre, Luciana Bonfante, Barbara Rossi, Francesco Marchini, Marta Fiscon, Alda Saldan, Luisa Barzon, Dino Sgarabotto, Davide Abate, Giorgio Palù, and Paolo Rigotti; Padua, Italy

 

                P-207     IMPACT OF CONTAMINATED PRESERVATION FLUID ON CADAVERIC KIDNEY ALLOGRAFT TRANSPLANT – 5 YEAR EXPERIENCE

Lasantha Seneviratne, Esha Abrol, Natasha Reed, Bimbi Fernando, Ben Lindsey, Mark Harber, Peter Veitch, and David Nicol; London, United Kingdom

 

                P-208     IS  ISONIAZID SAFE IN LIVER TRANSPLANT PATIENTS ON THE WAITING LIST?

Raquel S.B. Stucchi, Ilka F.S.F. Boin, Rocrigo N. Angerami, Leticia Zanaga, Elisabete Y. Udo, and Elaine C. Ataide; Campinas, Brazil

 

                P-209     CMV INFECTION AFTER HEART TRANSPLANTATION IN RELATION WITH DIFFERENT IMMUNOSUPRESSION

Jevgenija Vymetalova, and Ivan Malek; Prague, Czech Republic

 

                P-210     A COMPARATIVE STUDY OF GANCICLOVIR VS. ACYCLOVIR FOR CYTOMEGALOVIRUS INFECTION TREATMENT IN RENAL TRANSPLANT RECIPIENTS

Wujun Xue, Yang Li, Puxun Tian, Xiaoming Ding, Hang Yan, Xinshun Feng, Xiaoming Pan, Jun Hou, Heli Xiang, Xiaohui Tian, and Shengbin Li; Xi’an, China

 

                P-211     HEPATITIS C VIRUS (HCV) GENOTYPE MISMATCH IN RENAL TRANSPLANTATION AND HCV GENOTYPE CONVERSION

Kazuaki Yamanaka, Tomoko Kinoshita, Tetuji Soda, Takeshi Ishimura, Toshiaki Hirai, Hidehumi Kishikawa, Masashi Takeda, Kenji Nishimura, Mituo Hoshimoto, Masato Fujisawa, and Yasuji Ichikawa; Nishinomiya, Hyogo, Japan; and Kobe, Hyogo, Japan

Poster Session: Kidney

                P-212     PULSATILE PERFUSION PRESERVATION FOR EXPANDED-CRITERIA DONORS KIDNEYS: IMPACT ON DELAYED GRAFT FUNCTION RATE

Imad Abboud, Corinne Antoine, Tomas Serrato, Carmen Lefaucheur, Evangéline Pillebout, François Gaudez, Fabienne Fieux, Martin Flamant, Jérôme Verine, Denis Viglietti, Marie-Noëlle Peraldi, and Denis Glotz; Paris, France

 

                P-213     HAS LONG-TERM SURVIVAL OF KIDNEY TRANSPLANT STABILIZED NOWADAYS? PROJECTED HALF MEAN LIFE

María Luisa Agüera, Alberto Rodríguez-Benot, María Dolores Navarro, María Dolores Redondo, Maria José Pérez, Katia Toledo, Domingo Castillo, and Pedro Aljama; Córdoba, Spain

 

                P-214     DOES RETROPERITONOSCOPIC NEPHRECTOMY INCREASE THE RISK FOR LYMPHOCELE FORMATION?

Baris Akin, Erhan Sezer, Muammer Kaya, Murat Dayangac, Jale Saridogan, and Veday Celik; Istanbul, Turkey

 

                P-215     THE EXPERIENCE OF EXPANDED CRITERIA DONORS; KIDNEY TRANSPLANTATION IN SAUDI ARABIA: 2008-2010

Faissal A.M. Shaheen, Besher A. Al-Attar, Mohd. Ziad Souqiyyeh, Johny E. Cillo, and Abdulla A. Al-Sayyari; Riyadh, Saudi Arabia

 

                P-216     IMPACT OF THE DETERMINATION OF HLA ANTIBODIES IN KIDNEY TRANSPLANT OVER TEN YEARS OF MONITORING

Jackie Apaza, Esther Gonzalez, Natalia Polanco, Carlos Cadenillas, Ignacio Bengoa, Ana Hernandez, Amado Andres, and Jose Maria Morales; Madrid, Spain

 

                P-217     LAPAROSCOPIC RE-INSERTION/EXCHANGES OF PERITONEAL DIALYSIS CATHETERS (PDC) USING THE MODIFIED ‘Y’-TEC SYSTEM

Atul Bagul, Louisa C. Firmin, Umasankar M. Thiyagarajan, Jodie H. Frost, and Prof Michael L. Nicholson; Leicester, United Kingdom

 

                P-218     UROLOGICAL COMPLICATIONS AFTER RENAL TRANSPLANTATION

Catalin Baston, Mihai Harza, Bogdan Serbanescu, Bogdan Stefan, Marcian Antonio Manu, Vasile Cerempei, Bogdan Haineala, Silviu Guler Margaritis, Claudiu Codoiu, Bogdan Badescu, and Ionel Sinescu; Bucharest, Romania

 

                P-219     YOU’RE WELCOME: SUPPORTING YOUNG ADULTS WITH KIDNEY DISEASE

Clare A. Beard, Paul Harden, Bev Matthews, and Donal O’Donoghue; Newcastle upon Tyne, United Kingdom; Oxford, United Kingdom; and London, United Kingdom

 

                P-220     CINACALCET IMPROVES ENDOTHELIAL FUNCTION IN RENAL TRANSPLANT RECIPIENTS WITH PERSISTENT HYPERPARATHYROIDISM

Špela Borštnar, Damjan Kovac, Barbara Erzen, and Aljoša Kandus; Ljubljana, Slovenia

 

                P-221     KIDNEY TRANSPLANTATION FROM LIVING DONORS OVER 60: DONOR AGE DOES MATTER

Susanne Brakemeier, Klemens Budde, Josep M. Campistol, Rafael Cobera, Petra Glander, Lutz Liefeldt, Hans H. Neumayer, Federico Oppenheimer, Ignacio Revuelta, and Fritz Diekmann; Berlin, Germany; and Barcelona, Spain

 

                P-222     SAFE CONVERSION OF STABLE KIDNEY TRANSPLANT RECIPENTS FROM TWICE-DAILY TACROLIMUS (Prograf) TO ONCE-DAILY MODIFIED RELEASE TACROLIMUS (Advagraf)

Mario Carmellini, Giuliana Ruggieri, and Andrea Collini; Siena, Italy

 

                P-223     OPEN PROSPECTIVE STUDY TO EVALUATE CARDIOVASCULAR RISK FACTORS AND RENAL FUNCTION IN TWO DOSAGE REGIMENS OF TACROLIMUS (TAC) COMBINED WITH MYCOPHENOLATE MOFETIL AND STEROIDS IN RENAL TRANSPLANT PATIENTS

Andrzej Chamienia, Alicja Debska-Slizien, and Boleslaw Rutkowski; Gdansk, Poland

 

                P-224     SINGLE CENTRE EXPERIENCE IN LIVING DONOR KIDNEY TRANSPLANTATION (LDKT)

Andrzej Chamienia, Alicja Debska-Slizien, Boleslaw Rutkowski, Grazyna Moszkowska, Dariusz Zadrozny, and Zbigniew Sledzinski; Gdansk, Poland

 

                P-225     IMPACT OF CYP3A AND ABCB1 POLYMORPHISMS ON TACROLIMUS DOSE-ADJUSTED TROUGH CONCENTRATIONS AMONG RENAL TRANSPLANT RECIPIENTS IN KOREA

Jang-Hee Cho, Mi-Kyung Jin, Young-Deuk Yoon, Ja-Yong Park, Eun-Joo Song, Ji-Young Choi, Se-Hee Yoon, Sun-Hee Park, Yong-Lim Kim, and Chan-Duck Kim; Degu, Republic of Korea

 

                P-226     RENAL TRANSPLANTATION FOLLOWING AORTO-ILIAC RECONSTRUCTION IS A SAFE A STRATEGY

Celine Dubuis, Sebastien Deglise, Francois Saucy, Bertrand Saint-Lebes, Jean-Pierre Venetz, Manuel Pascual, and Jean-Marc Corpataux; Lausanne, Switzerland

 

                P-227     CONVERSION TO EVEROLIMUS: TO BELIEVE OR NOT BELIEVE?

Patricia Cotovio, Marta Neves, Lídia Santos, Fernando Macário, Rui Alves, and Alfredo Mota; Coimbra, Portugal

 

                P-228     THE INFLUENCE OF OBESITY ON RENAL TRANSPLANT OUTCOMES – A PAIRED KIDNEYS ANALYSIS

Zuzanna Wolyniec, Alicja Debska-Slizien, and Boleslaw Rutkowski; Gdansk, Poland

 

                P-229     ESTIMATING MODEL OF GRAFT FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS

Viktor K. Denisov, and Ann S. Ksenofontova; Donetsk, Ukraine

 

                P-230     PREGNANCY IN KIDNEY TRANSPLANT: RESULTS IN 2 NORTH EAST ITALY TRANSPLANTATION CENTRES

Pierluigi Di Loreto, Francesca Martino, Claudio Ronco, Pasquale Catapano, and Domenico Montanaro; Vicenza, Italy; and Udine, Italy

 

                P-231     MANAGEMENT OF LOCALIZED PROSTATE CANCER BY RETROPUBIC RADICAL PROSTATECTOMY IN KIDNEY RECIPIENTS

Arnaud Doerfler, Bruno Hurault de Ligny, Sophie Le Toquin-Bernard, Sophie Le Gal, and Henri Bensadoun; Caen, France

 

                P-232     LEFT VENTRICULAR HYPERTROPHY AFTER KIDNEY TRANSPLANTATION

Katarzyna Slubowska, Anna Sadowska, Barbara Lichodziejewska, Katarzyna Kurnicka, Zbigniew Galazka, Andrzej Chmura, and Magdalena Durlik; Warsaw, Poland

 

                P-233     A YEAR AFTER THE DONOR/RECIPIENT SERVICE SPLIT – ONE RECIPIENT TEAM’S EXPERIENCE

Diane Evans, and Shirley Dowle; Bristol, United Kingdom

 

                P-234     DONOR SPECIFIC ANTIBODIES (DSA): CAUSES AND CONSEQUENCES

AM Fernandez-Rodriguez, F. Diez, G. Galeano, R. Marcen, C. Quereda, J. Burgos, and J.L. Castañer; Madrid, Spain

 

                P-235     NEW ONSET DIABETES MELLITUS AFTER TRANSPLANTATION: RISK FACTORS AND CONSEQUENCES

Inese Folkmane, Cristoph Folkmanis, Janis Bicans, Rafail Rosentha, and Ajanthan Johendranathan; Riga, Latvia; Scunthorpe, United Kingdom

 

                P-236     DOUBLE KIDNEY TRANSPLANTATION IN A SINGLE-CENTER

Iris Fontana, Massimo Bertocchi, Gregorio Santori, and Umberto Valente; Genoa, Italy

 

                P-237     ASSESSING OUTCOME OF ARTERIOVENOUS FISTULAE (AVF) IN RENAL HAEMODIALYSIS PATIENTS WITH AN INDWELLING TUNNELLED DIALYSIS CATHETER (TDC)

Jodie H. Frost, Atul Bagul, Umasankar M. Thiyagarajan, and Michael L. Nicholson; Leicester, United Kingdom

 

                P-238     IS INTRAVENOUS IMMUNOGLOBULIN AN EFFECTIVE TREATMENT FOR ACUTE ANTIBODY-MEDIATED REJECTION?

Lucy Galloway, Iek Cheng, Anthony Dorling, Rachel Hilton, and Nizam Mamode; London, United Kingdom

 

                P-239     IMPACT OF DONOR KIDNEY SIZE ON ALLOGRAFT FUNCTIONS IN LIVING DONOR RENAL TRANSPLANTS: DOES SIZE MATTER?

Abbas Ghazanfar, Gabriele Di Benedetto, David Vandellen, Maria Mito Pretorian, Ravi Pararajasingam, Titus Augustine, and Afshin Tavakoli; Manchester, United Kingdom

 

                P-240     ERECTILE DYSFUNCTION AMONG PATIENTS WITH END STAGE RENAL DISEASE: A COMPARISON STUDY BETWEEN HAEMODIALYSIS, CONTINUOUS AMBULATORY PERITONEAL DIALYSIS AND RENAL TRANSPLANT PATIENTS

Bak-Leong Goh, Eng-Khim Ng, Mohd Rozi, Siew Eng Chew, and N. Noraziah; Kajang, Malaysia

 

                P-241     EARLY BEDSIDE REMOVAL VERSUS LATE CYSTOSCOPIC REMOVAL OF URETERIC STENTS FOLLOWING RENAL TRANSPLANTATION; DOES IT MAKE A DIFFERENCE?

Nalaka Gunawansa, Rezni Cassim, Anuja Abeydheera, and Mandika Wijeyaratne; Colombo, Sri Lanka

 

                P-242     SERUM PARAOXANASE 1 ACTIVITY PREDICTS ARTERIAL STIFFNESS IN RENAL TRANSPLANT PATIENTS

Ozkan Gungor, Fatih Kircelli, Meltem Sezis Demirci, Pinar Balci, Ali Riza Sisman, Erhan Tatar, Ender Hur, Gulay Asci, Ercan Ok, and Huseyin Toz; Izmir, Turkey

 

                P-243     STUDY OF FACTORS AFFECTING GRAFT AND PATIENT SURVIVAL WITHIN FIVE YEARS  OF RENAL TRANSPLANTATION

Krishan L. Gupta, Pinaki Mukherjee, Mukut Minz, Harbir Kohli, Vivekanand Jha, and Vinay Sakhuja; Chandigarh, India

 

                P-244     EARLY PROGRESSION OF AMYLOIDOSIS IN A RENAL TRANSPLANT RECIPIENT WITH FAMILIAL MEDITERRANEAN FEVER

Medhat M.A. Halim, Torki Al-Otaibi, Osama Gheith, Hany Adel, Ahmed Musaad, Biju Vareed, Deepak S. Pillai, Tarek Said, Prasad Nair, and M.R.N. Nampoory; Kuwait, Kuwait

 

                P-245     EFICACY AND SIDE EFFECTS OF H1N1 VACCINATION IN RENAL TRANSPLANT AND DIALYSIS PATIENTS

R. Allwin, S. Gauer, Roessel, H. Hoefeld, M. Brzoska, S.K. Han, J. Gossmann, V. Belwe, H. Geiger, and I.A. Hauser; Frankfurt, Germany

 

                P-246     COMPLICATIONS OF KIDNEY TRANSPLANTATION FROM DONORS AFTER CARDIAC DEATH (DCD)

Szabolcs Horvath, David Archampong, Pramod Nagaraja, Gareth Roberts, Michael Stephens, Jana Fialova, Sian Griffin, Rafael Chavez, Argiris Asderakis, and Zsolt Kaposztas; Cardiff, United Kingdom

 

                P-247     UROTENSIN II LEVELS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND KIDNEY TRANSPLANTS

Mehmet Hursitoglu, Tufan Tukek, Mehmet Ali Cikrikcioglu, Osman Kara, Rumeyza Kazancioglu, Oktay Ozkan, Mustafa Cakirca, Fatih Akdogan, Erdal Gundogan, Sengul Aydin, Ismet Beycan, Meltem Gursu, Serkan Dogan, and Aybala Erek; Istanbul, Turkey

 

                P-248     EFFECTS OF CONVERSION FROM TACROLIMUS TO TACROLIMUS EXTENDED-RELEASE ON TREATMENT ADHERENCE IN KIDNEY TRANSPLANT PATIENTS

Naotsugu Ichimaru, Taigo Kato, Koichi Tsutahara, Yoichi Kakuta, Toyofumi Abe, Masayoshi Okumi, Koji Yazawa, Norio Nonomura, Junya Kaimori, and Shiro Takahara; Osaka, Japan; and Suita, Japan

 

                P-249     THE PROGNOSTIC IMPACT OF DONOR-SPECIFIC ANTIBODY (DSA) LEVELS TO PREDICT SEVER ACUTE ANTIBODY MEDIATED REJECTION IN LIVING KIDNEY TRANSPLANTATION

Rie Imaizumi, Yasuo Ishii, Kazuhiro Iwadoh, Katsuyuki Miki, Shinji Kudoh, Toru Murakami, Ichiro Koyama, Ichiro Nakajima, and Shouhei Fuchinoue; Tokyo, Japan

 

                P-250     THE IMPACT OF HUSBAND-TO-WIFE SPOUSAL RENAL TRANSPLANTATION ON ACUTE REJECTION IN TERMS OF DONOR-SPECIFIC ANTIGEN

Katsuyuki Miki, Kazuhiro Iwadoh, Yasuo Ishii, Yusuke Tomita, Rie Imaizumi, Toru Murakami, Ichiro Koyama, Ichiro Nakajima, and Shouhei Fuchinoue; Tokyo, Japan

 

                P-251     BENEFITIAL EFFECT OF UBIQUINOL, THE REDUCED FORM OF COENZYME Q10, ON CYCLOSPORINE-INDUCED NEPHROTOXICITY

Akira Ishikawa, and Yukio Homma; Tokyo, Japan

 

                P-252     SLOW EARLY GRAFT FUNCTION: A NEGLECTED ENTITY AFTER RENAL TRANSPLANTATION

Daniel Nel, John Vogel, Elmi Muller, Zunaid Barday, and Delawir Kahn; Cape Town, South Africa

 

                P-253     HEPATITIS B REACTIVATION FOLLOWING KIDNEY TRANSPLANTATION: INCIDENCE AND RISK FACTORS

Nada Kanaan, Benoit Kabamba, Céline Maréchal, Eric Goffin, and Ziad Hassoun; Brussels, Belgium

 

                P-254     DONOR KIDNEY WEIGHT TO RECIPIENT BODY-WEIGHT RATIO IS AN IMPORTANT RISK FACTOR FOR LONG-TERM OUTCOME OF LIVING DONOR KIDNEY TRANSPLANTATION

Ji Il Kim, Jeong-Kye Hwang, and In-Sung Moon; Seoul, Korea

 

                P-255     KIDNEYS FROM DECEASED DONORS WITH OLIGURIA ARE FEASIBLE FOR KIDNEY TRANSPLANTATION

Jong Man Kim, Sanghyun Song, Milljae Shin, Hyung Hwan Moon, Young Nam Moon, Hyun Sun Ji, Jong Hwan Lee, Choon Hyuck D. Kwon, Jae-Won Joh, and Sung-Joo Kim; Seoul, Korea

 

                P-256     HORMONAL DIFFERENCE IN BETWEEN FEMALE KIDNEY TRANSPLANT RECIPIENTS AND HEALTHY WOMEN WITH ENDOCRINOLOGIC PROBLEMS IN GYNECOLOGY

Jong Man Kim, Sanghyun Song, Milljae Shin, Hyung Hwan Moon, Young Nam Noh, Hyun Sun Ji, Choon Hyuck D. Kwon, Jae-Won Joh, and Sung Joo Kim; Seoul, Korea

 

                P-257     DEEP VEIN THROMBOSIS IMMEDIATELY AFTER KIDNEY TRANSPLANTATION

Ji Il Kim, Jeong Kye Hwang, and In Sung Moon; Seoul, Korea

 

                P-258     SHORT-TERM RESULTS OF ABO-INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION: COMPARISON WITH ABO-COMPATIBLE GRAFTS

Ji Il Kim, Jeong Kye Hwang, and In Sung Moon; Seoul, Korea

 

                P-259     CLINICAL RELEVANCE OF POST TRANSPLANT DE NOVO HLA ANTIBODIES AFTER LIVING DONOR KIDNEY TRANSPLANTATION

Martina Koch, Thomas Eiermann, Almut Vernauer, Werner Tenschert, Friedrich Thaiss, and Bjoern Nashan; Hamburg, Germany

 

                P-260     HLA-C MISMATCH AFFECTS SHORT-TERM RENAL TRANSPLANT FUNCTION

Hoey C. Koh, Claire Burt, Marc Gingell-Littlejohn, Ann-Margaret Little, and Marc J. Clancy; Glasgow, United Kingdom

 

                P-261     THE QUALITY OF LIFE IN LIVING DONOR KIDNEY TRANSPLANTATION

Myoung Hee Kim, Oh Jung Kwon, and ChongMyung Kang; Seoul, Korea

 

                P-262     COMPARISON OF SERUM CYSTATIN C AND CREATININE AS A MARKER FOR EARLY DETECTION OF DECREASING GLOMERULAR FILTRATION RATE IN RENAL TRANSPLANTATION PATIENTS

Oh Jung Kwon, Hayng Ran Lee, and Jin Young Kwak; Seoul, Korea

 

                P-263     PREGNANCY IN KIDNEY TRANSPLANT PATIENTS

Vérónica López, Dolores Martínez, Carmen Viñolo, Mercedes Cabello, Eugenia Sola, Cristina Gutiérrez, Dolores Burgos, and Domingo Hernández; Malaga, Spain

 

                P-264     REDUCTION IN PROTEINURIA AFTER DUAL BLOCKADE OF THE RENIN-ANGIOTENSIN SYSTEM (ARB II-ALISKIREN) IN KIDNEY TRANSPLANT PATIENTS

Verónica López, Cristina Jironda, Mónica Martín, Carmen Cobelo, Eugenia Sola, Mercedes Cabello, Cristina Gutiérrez, Dolores Burgos, Miguel González-Molina, and Domingo Hernández; Malaga, Spain

 

                P-265     JC POLYOMAVIRUS: DOES IT CAUSE NEPHROPATHY IN RENAL TRANSPLANT PATIENTS?

Verónica López, Cristina Gutiérrez, Eugenia Sola, Dolores Burgos, Mercedes Cabello, Miguel González-Molina, and Domingo Hernández; Málaga, Spain

 

                P-266     HISTOLOGICAL FINDINGS IN RENAL TRANSPLANT PATIENTS WITH PROTEINURIA

Verónica López, Eugenia Sola, Cristina Jironda, Mirian León, Isabel García, Cristina Gutiérrez, Mercedes Cabello, Dolores Burgos, Miguel González-Molina, and Domingo Hernández; Málaga, Spain

 

                P-267     RESTROSPECTIVE ANALYSIS OF INDUCTION THERAPY (IT) FOR KIDNEY TRANSPLANTATION IN A SINGLE CENTER POPULATION OVER 17 YEARS

Antonio Lavacca, Maria Massina, Caterina Dolla, Ester Gallo, Giuliana Tognarelli, Vincenzo Cantaluppi, Roberta Giraudi, and Giuseppe P. Segoloni; Turin, Italy

 

                P-268     SEVERE NEUROLOGICAL COMPLICATIONS(SNC) IN KIDNEY TRANSPLANTATION (KT)

Sebastian P. Jaurretche, Maria A. Gini, Ana M. Linchenco, Pablo G. Candusso, José L. Sgrosso, and Maria C. Vazquez; Rosario, Argentina

                                                                                               

                P-269     SERUM  HOMOCYSTEINE  THIOLACTONASE  AND  PARAOXONASE  ACTIVITY  IN RENAL  TRANSPLANTED  PATIENTS

Lajos Locsey, Ildiko Seres, Ferenc Sztanek, Mariann Harangi, Janos Padra, Laszlo Asztalos, and Gyorgy Paragh; Debrecen, Hungary

 

                P-270     CONVERSION TO EVEROLIMUS IN PATIENTS WITH NEPHROTOXICITY INDUCED BY CALCINEURIN INHIBITORS. ONE YEAR EVOLUTION AS PER BASELINE BIOPSY FINDINGS

P.U. Massari, C. Chiurchiu, C. Agost Carreño, P. Novoa, F. Acosta, M. Arriola, H. Trimarchi, F. Lopez, H. Petrone, J. Davalos Michel, C. Balaguer, R. Schiavelli, and F. Cicora; Cordoba, Argentina; Buenos Aires, Argentina; Rosario, Argentina; Santa Fe, Argentina; Resistencia, Argentina; La Plata, Argentina; and Mendoza, Argentina

 

                MC900354038[1]P-271              RENAL VESSEL MULTIPLICITY AND ITS IMPACT ON PERIOPERATIVE AND LONG-TERM DONOR OUTCOMES FOLLOWING LIVING-DONOR NEPHRECTOMY

Sotiris Mastoridis, Benjamin O’Brien, Atika Sabharwal, David Taube, Nadey Hakim, and Vassilios Papalois; London, United Kingdom

 

                P-272     UROLOGICAL COMPLICATIONS FOLLOWING RENAL TRANSPLANTATION- A SINGLE CENTRE EXPERIENCE

Umasankar Mathuram Thiyagarajan, Prarthana Thiyagarajan, Atul Bagul, and Michael L. Nicholson; Leicester, United Kingdom

 

                P-273     IMBALANCE OF MMPs/TIMPs SYSTEM IN RENAL TRANSPLANT RECIPIENTS WITH CHRONIC ALLOGRAFT INJURY

Oktawia Mazanowska, Dorota Kaminska, Magdalena Krajewska, Marcelina Zabinska, Waclaw Kopec, Maria Boratynska, and Marian Klinger; Wroclaw, Poland

 

                P-274     VARIATION OF THE KIDNEY GRAFT VESSELS DURING LAPAROSCOPIC LIVING DONOR NEPHRECTOMY (LLDN): SURGICAL MANAGEMENT AND IMPACT ON EARLY GRAFT FUNCTION

Anh Dung Hoang, Dimitri Mikhalski, Alexis Buggenhout, Patricia Loi, Daniel Abramowicz, Nilufer Broeders, and Vincent Donckier; Brussels, Belgium

 

                P-275     eGFR AND 1-HOUR BIOPSY ARE BETTER PREDICTORS OF DECEASED KIDNEY TRANSPLANTS WITH USING IN-SITU-COOLING DOUBLE-BALLOON CATHETERS SYSTEM

Kazuo Mizutani, Ryohei Hattori, Tsuneo Kinukawa, Osamu Kamihira, and Momokazu Gotoh; Nagoya, Japan; and Komaki, Japan

 

                P-276     DISTRIBUTION OF RENAL HISTOPATHOLOGY FINDINGS IN GUILAN PROVINCE, NORTH OF IRAN DURING 2001 TO 2006

Ali Monfared, Seyed Amin Mosavian Roshanzamir, Saba Hoda, and Sepiedeh Besharati; Rasht, Islamic Republic of Iran

 

                P-277     LIVING DONOR KIDNEY TRANSPLANTATION IN CROSSMATCH-POSITIVE PATIENTS ENABLED BY PERITRANSPLANT IMMUNOADSORPTION AND ANTI-CD20 THERAPY

Christian Morath, Jorg Beimler, Gerhard Opelz, Sabine Scherer, Jan Schmidt, Marie-Luise Gross, Claudia Sommerer, Vedat Schwenger, Martin Zeier, and Caner Susal; Heidelberg, Germany

 

                P-278     ATTITUDES AND PRACTICES TOWARDS RENAL TRANSPLANTATION IN SICKLE CELL SYNDROMES AMONGST UK TRANSPLANT CENTRES

Jay Nath, James McDaid, Andrew Bentall, Simon Ball, Andrew R. Ready, and Nicholas G. Inston; Birmingham, United Kingdom

 

                P-279     RESTARTING A LIVING DONOR KIDNEY TRANSPLANT PROGRAM IN KENYA: 24 TRANSPLANTS PERFORMED IN LESS THAN ONE YEAR

John Ngigi, Anthony Were, James Munene, Thomas Chokwe, Peter Mungai, Samuel Kanyi, Divinia Nyarera, Ana Palacio, Conchita Monsalve, Nuria Saval, Nathalie Cretin, Antonio Alcaraz, and Federic Oppenheimer; Nairobi, Kenya; Barcelona, Spain; Barcelona, St. Helena; and Basel, Switzerland

 

                P-280     IMPACT OF LOW SERUM ADIPONECTIN LEVELS ON ARTERIAL STIFFNESS IN NEW ONSET DIABETES AFTER RENAL TRANSPLANTATION

Kenji Nishimura, Toshiaki Hirai, Ayako Okuno, Tetsuji Soda, Shigeaki Nakazawa, Sayoko Yonemoto, Kazuaki Yamanaka, Naohiko Fujii, Hidefumi Kishikawa, and Yasuji Ichikawa; Nishinomiya, Japan

 

                P-281     VALIDATION OF THE SIMPLIFIED MEDICATION ADHERENCE QUESTIONNAIRE (SMAQ) IN RENAL TRANSPLANT PATIENTS ON TACROLIMUS

Francisco J. Ortega, Jaime Sánchez, Miguel A. Pérez, Porfirio Pereira, Miguel A. Muñoz, and Dolores Lorenzo; Oviedo, Spain; Valencia, Spain; Las Palmas, Spain; Sevilla, Spain; Toledo, Spain; and A Coruña, Spain

 

                P-282     THE DIFFERENCES IN THE POST-TRANSPLANT LYMPHOCELES IN DEPENDENCY ON THEIR ORIGIN

Jaroslav Pacovsky, Radomir Hyspler, Pavel Navratil, Lukas Holub, and Milos Brodak; Hradec Kralove, Czech Republic

 

                P-283     THE LONG-TERM RESULTS FOLLOWING THE TREATMENT OF THE POST-TRANSPLANT SYMPTOMATIC LYMPHOCELES

Jaroslav Pacovsky, Radomir Hyspler, Pavel Navratil, and Milos Brodak; Hradec Kralove, Czech Republic

 

                P-284     HIGH LYMPHOCYTE COUNTS IN THE EARLY POST-TRANSPLANT COURSE OF KIDNEY ALLOGRAFT RECIPIENTS CARRYING IMPDH II 3757 T>C SNP

Joanna Pazik, Monika Oldak, Zbigniew Lewandowski, Grzegorz Bubak, Malgorzata Puzon, Marta Podgórska, Elzbieta Sitarek, Rafal Ploski, Jacek Malejczyk, and Magdalena Durlik; Warsaw, Poland

 

                P-285     WEIGHT GAIN IN KIDNEY ALLOGRAFT RECIPIENTS CARRYING MDR2 2 4544G>A POLYMORPHISM

Joanna Pazik, Monika Oldak, Zbigniew Lewandowski, Elzbieta Sitarek, Malgorzata Puzon, Grzegorz Bubak, Rafal Ploski, Jacek Malejczyk, and Magdalena Durlik; Warsaw, Poland

 

                P-286     DOES PRE-OPERATIVE SPLIT RENAL FUNCTION TESTING PREDICT RESIDUAL POST-DONATION FUNCTION IN LIVING DONOR TRANSPLANTATION?

Robin Polson, Alex P. Navarro, Alun R. Williams, Amanda J. Knight, Keith M. Rigg, and Shantanu Bhattacharjya; Nottingham, United Kingdom

 

                P-287     CREATININE REDUCTION RATIO ON DAY 2: THE USEFUL MARKER FOR TRANSPLANT OUTCOME IN PATIENTS WITH LIVING DONOR TRANSPLANTATION

Irena Rambabova Busljetic, Popov Zivko, Jelka Masin, Galina Severova, Anita Hristova Dimcevska, and Ninoslav Ivanovski; Skopje, Macedonia

 

                P-288     LARGE ANIMAL RENAL ALLOTRANSPLANTATION; A PORCINE RECOVERY MODEL TO ASSESS DELAYED GRAFT FUNCTION

Christopher Ray, Muhammad Khurram, Omar Mownah, Aditya Kanwar, Susan Stamp, John Brassil, Douglas Rees, Kathryn White, Katrina Wood, Kelly Philipson, Robert Peaston, Aurelie Thomas, Anne Cunningham, Paul Flecknell, Noel Carter, and David Talbot; Sunderland, United Kingdom; and Newcastle upon Tyne, United Kingdom

 

                P-289     COMPARISON AMONG ACUTE REJECTION MEDITED BY CELLULAR AND ANTIBODY MECHANISMS IN PATIENTS SUBMITTED TO IDENTIFICATION OF C4d AND DSA IN RENAL BIOPSY

Lucio R. Requião-Moura, Eduardo J. Tonato, Erika A. Ferraz, Rogerio Chinen, Thiago C. Filliponi, Ana Cristina C.C. Mattos, Marcelino S. Durão, and Alvaro Pacheco-Silva; São Paulo, Brazil

 

                P-290     CARDIOVASCULAR RISK ASSESSMENT FOR RENAL TRANSPLANTATION. ARE PATIENTS BEING MANAGED APPROPRIATELY IN OUR HOSPITAL?

James Rigby, Selva Velu, and Mark Gunning; Stoke-on-Trent, United Kingdom

 

                P-291     COMPARISON OF THE EFFICACY AND SAFETY OF CALCINEURIN INHIBITOR CONVERSION TO mTOR INHIBITOR AND CNI MINIMIZATION IN KIDNEY TRANSPLANTS WITH CHRONIC ALLOGRAFT NEPHROPATHY

Piyarat Rojsanga, Attapong Vongwiwatana, Nalinee Premasathian, and Somkiat Vasuvattakul; Bangkok, Thailand

 

                P-292     PREDICTIVE REGRESSION MODELS IN A SINGLE-CENTER SERIES OF DOUBLE KIDNEY TRANSPLANTATION

Gregorio Santori, Iris Fontana, Massimo Bertocchi, Sergio Barocci, Arcangelo Nocera, and Umberto Valente; Genoa, Italy

 

                P-293     THYMOGLOBULIN INDUCTION IN LIVING-DONOR RENAL TRANSPLANTATION

Peter Schenker, Arzu Öztürk, Oliver Vonend, Bernd Krüger, Martin Jazra, Bernhard K. Krämer, and Richard Viebahn; Bochum, Germany; Düsseldorf, Germany; and Mannheim, Germany

 

                P-294     EARLY DIAGNOSIS  AND IMPACT OF TRANSPLANT RENAL ARTERY STENOSIS TREATED BY ANGIOPLASTY

Lasantha N. Seneviratne, Prabal Mittal, Anthony Goode, Ben Lindsey, Bimbi Fernando, Mark Harber, Peter Veitch, and David Nicol; London, United Kingdom

 

                P-295     THE EFFECT OF COLD ISCHEMIA TIME ON THE DELAYED GRAFT FUNCTION AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION

Ismail Sert, Sait Murat Dogan, Cem Tugmen, Eyüp Kebabci, Ragip Kayar, and Cezmi Karaca; Izmir, Turkey

 

                P-296     ALLOGRAFT OUTCOME OF SPOUSAL AND LIVING UNRELATED RENAL TRANSPLANTATION

Taylan O. Sezer, Huseyin Toz, Erhan Tatar, Ceyhun Isayev, Ozgur Firat, Ilhami Solak, and Cuneyt Hoscoskun; Izmir, Turkey

 

                P-297     SIGNIFICANT ASSOCIATION BETWEEN RESULT OF NOVEL CROSSMATCH TEST AND ANTIBODY-MEDIATED REJECTION AFTER RENAL TRANSPLANTATION

Yusuke Shiraishi, Michio Nojima, Tomoko Kinoshita, Mitsuo Hashimoto, Yasuo Ueda, Hidefumi Kishikawa, Masashi Takeda, Masato Fujisawa, Yasuji Ichikawa, and Shingo Yamamoto; Nishinomiya, Japan; and Kobe, Japan

 

                P-298     OUTCOMES OF LIVE KIDNEY DONOR WORK-UP: A SINGLE CENTRE EXPERIENCE

Caroline Basarab-Horwath, Carole Clayton, Lisa Hamilton, Veronica Lennon, Peter W.G. Brown, and Badri Man Shrestha; Sheffield, United Kingdom

 

                P-299     ESTIMATED GLOMERULAR FILTRATION RATE AND LONG-TERM OUTCOMES FOLLOWING LIVE KIDNEY DONATION: A SINGLE CENTRE EXPERIENCE

Carole Clayton, Lisa Hamilton, Caroline Basarab-Horwath, Veronica Lennon, and Badri Man Shrestha; Sheffield, United Kingdom

 

                P-300     DOES CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION HAVE BETTER PROGNOSIS THAN CHRONIC T- CELL MEDIATED REJECTION?

Janka Slatinska, Eva Honsova, Marcela Burgelova, Eva Slimackova, and Ondrej Viklicky; Prague, Czech Republic

 

                P-301     PROGNOSTIC ROLE OF PRE-TRANSPLANT DONOR KIDNEY BIOPSIES

Vadims Suhorukovs, Janis Jushinskis, and Tatjana Tihomirova; Riga, Latvia

 

                P-302     INFLUENCE OF POLYMORPHISMS GLUTATHIONE S-TRANSFERASE AND ANTI-GSTT1 ANTIBODY ON ALLOGRAFT OUTCOME IN RENAL TRANSPLANT RECIPIENTS

Sebahat Usta, Yasar Çaliskan, Hakan Gürkan, Çigdem Kekik, Fatma O. Savran, and Aydin Türkmen; Istanbul, Turkey

 

                P-303     TREATMENT OF VITAMIN D DEFICIENCY AND ITS IMPACT ON ALBUMIN EXCRETION IN KIDNEY TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL

Ursula Thiem, Alois Gessl, Georg Heinze, Ute Gössler, Thomas Perkmann, Franz Kainberger, Ferdinand Mühlbacher, Walter H. Hörl, and Kyra Borchhardt; Vienna, Austria

 

                P-304     RENAL FUNCTION MONITORING AFTER ORTHOTOPIC LIVER TRANSPLANTATION: ONE YEAR FOLLOW-UP

Francesca Tinti, Ilaria Umbro, Valerio Giannelli, Manuela Merli, Stefano Ginanni Corradini, Massimo Rossi, Luca Poli, Pasquale B. Berloco, and Anna Paola Mitterhofer; Rome, Italy

 

                P-305     ACTIVATION OF MITOCHONDRIAL APOPTOTIC PATHWAY IN CADAVER KIDNEY TRANSPLANTATION LEADS TO THE SLOW GRAFT FUNCTION (SGF)

Olexander S. Nikonenko, Andriy V. Trailin, and Tamara M. Nikonenko; Zaporizhzhya, Ukraine

 

                P-306     VENOUS DISPOSITION PROCEDURE (VDP) ON THE SHORT RENAL VEIN  REMOVING BY LAPAROSCOPY: A SIMPLE PROCEDURE

Sinh Ng Tran, and Thu Thi Ngoc Du; Ho Chi Minh City, Viet Nam

 

                P-307     THE EFFECT OF ANEMIA ON KIDNEY FUNCTION IN LIVING KIDNEY TRANSPLANTATION

Makoto Tsujita, Takehiko Kawaguchi, Takayuki Yamamoto, Takahisa Hiramitsu, Koji Nanmoku, Norihiko Goto, Yoshihiko Watarai, and Kasuharu Uchida; Nagoya, Japan

 

                P-308     SUCCESSFUL ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION IN PATIENT WITH CONGENIAL AFIBRINOGENEMIA: FIRST CASE REPORT

Yasuo Ueda, Michio Nojima, Akihiko Sawada, Yusuke Shiraishi, Yoshihide Higuchi, and Shingo Yamamoto; Nishinomiya, Japan

 

                P-309     HEMODIALYSIS ARTERIOVENOUS FISTULA IN KIDNEY TRANSPLANT RECIPIENTS: COMPLICATIONS AND SURGICAL INTERVENTIONS

Barbara Vajdic, Rafael Ponikvar, Aljosa Kandus, and Jadranka Buturovic-Ponikvar; Ljubljana, Slovenia

 

                P-310     LIVE KIDNEY TRANSPLANTATION: DO TRAINEES MAKE THE GRADE?

David van Dellen, Otilia M. Mitu-Pretorian, Melissa Cunha, Abbas Ghazanfar, Bence Forgacs, Ravi Pararajasingam, Babatunde Campbell, Hany N. Riad, Neil R. Parrott, Titus Augustine, and Afshin Tavakoli; Manchester, United Kingdom

 

                P-311     ePTFE SUTURE ANASTOMOSIS: AN EFFECTIVE TOOL IN VASCULAR KIDNEY TRANSPLANTATION?

Francesca Villa, Matteo Tozzi, Gabriele Piffaretti, Marco Franchin, Giuseppe Ietto, Fabrizio Rossi, and Giulio Carcano; Varese, Italy

 

                P-312     LATE SEVERE NON-INFECTIOUS DIARRHEA AFTER RENAL TRANSPLANTATION: HIGH RISK FACTORS, THERAPY AND PROGNOSIS

Jiqiu Wen, Jinsong Chen, Shuming Ji, Dongrui Cheng, Qiquan Sun, Xue Li, and Zhihong Liu; Nanjing, China

 

                P-313     HLA-DR OVEREXPRESS ON THE TUBULAR OF RENAL ALLOGRAFT IN EARLY ACUTE CELLULAR REJECTION AND LATE REJECTION IN RENAL TRANSPLANTATION

Jiqiu Wen, Jinsong Chen, Shuming Ji, Dongrui Cheng, Qiquan Sun, and Zhihong Liu; Nanjing, China

 

                P-314     WHAT HARM DO WE DO TO OUR ELDERLY PATIENTS? – THE BRIDGE BETWEEN EVIDENCE BASED MEDICINE AND REAL LIFE IN TRANSPLANT MEDICINE

Gerhard H. Wirnsberger, Matthias Koelbl, and Regina E. Roller-Wirnsberger; Graz, Austria

 

                P-315     PURE LAPAROSCOPIC LIVE DONOR NEPHRECTOMY RESULTS: A SINGLE INSTITUTION EXPERIENCE

Hakan Sozen, Utku Yilmaz, Lutfi Tunc, and Aydin Dalgic; Ankara, Turkey

 

                P-316     DONOR DNA LEVEL IN BLOOD OF KIDNEY ALLOGRAFT RECIPIENTS – CAN IT BE USED AS A DIAGNOSTIC FACTOR FOR REJECTION

Malgorzata Zagozda, Andrzej Rydzewski, Marek Durlik, and Waldemar L. Olszewski; Warsaw, Poland

 

                P-317     IS IT POSSIBLE TO REDUCE THE RISK OF THROMBOSIS OF VEIN IN RIGHT KIDNEY ALLOGRAFT?HOW?

Afshar Zomorrodi, Farzad Kakai, and Sahar Zomorrodi; Tabriz, Islamic Republic of Iran

 

                P-318     IS LEAVING EXPANSION PLACE FOR SUTURE IN ANASTOMOSIS OF VESSEL SAFE AND HELPFUL FOR PREVENTION OF STENOSIS?

Afshar Zomorrodi, Aboulfazel Bahloli, Farzad Kakai, and Sahar Zomorrodi; Tabriz, Islamic Republic of Iran

 

                P-319     REVASCULARIZATION OF TRANSPLANT RENAL ARTERY STENOSIS: DOPPLER ASSESSMENT

Ana Zupunski Cede, Vanja Peršic, Aljoša Kandus, and Jadranka Buturovic-Ponikvar; Ljubljana, Slovenia

Poster Session: Liver and Intestine

                P-320     RESULTS OF LIVER TRANSPLANTATION CRYPTOGENIC CIRRHOSIS: LONG-TERM FOLLOW-UP

José María Álamo, Carmen Benal, Luis Miguel Marín, Lydia Barrera, Gonzalo Suárez, Juan Serrano, Javier Padillo, and Miguel Ángel Gómez; Seville, Spain

 

                P-321     RESULTS OF LIVER TRANSPLANT WITH DONORS OLDER THAN 70

José María Álamo, Lydia Barrera, Luis Miguel Marín, Carmen Bernal, Gonzalo Suárez, Juan Serrano, Francisco Javier Padillo, and Miguel Ángel Gómez; Seville, Spain

 

                P-322     A HIGH MELD SCORE RELATES TO LOWER EMPLOYMENT RATES AFTER LIVER TRANSPLANTATION

Fredrik Åberg, Krister Höckerstedt, Risto P. Roine, and Helena Isoniemi; Helsinki, Finland

 

                P-323     PREVENTION OF SMALL-FOR-SIZE GRAFT SYNDROME IN LIVING DONOR LIVER TRANSPLANTATION BY PORTOCAVAL SHUNT GRAFTING WITH A BIOABSORBABLE SYNTHETIC VESSEL

Masayasu Aikawa, Mitsuo Miyazawa, Yosuke Ueno, Katsuya Okada, Yasuko Toshimitsu, Nobuji Ogawa, and Isamu Koyama; Saitama, Japan

 

                P-324     LIVER DONATION AND TRANSPLANTATION IN SAUDI ARABIA

Faissal A.M. Shaheen, Besher A. Al-Attar, Rogelio Q. Mendez, Jr., Zayed Mohd. Ibrahim, and Elsayed A. Gadalla; Riyadh, Saudi Arabia

 

                MC900354038[1]P-325              CHANCE OF SALVAGE TRANSPLANTATION AFTER PRIMARY HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA: A SPECIAL REFERENCE TO UP-TO-7 CRITERIA

Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Michihito Asanoma, and Shinichiro Yamada; Tokushima, Japan

 

                P-326     REVERSIBLE SEVERE IMMUNOLOGICAL AND INFECTIOUS COMPLICATIONS IN INTESTINE TRANSPLANT: A CASE REPORT

Claudia Bösmüller, Matthias Biebl, Stefan Schneeberger, Robert Öllinger, Felix Aigner, Sascha Weiß, Rupert Oberhuber, Christian Ensinger, and Johann Pratschke; Innsbruck, Austria

 

                P-327     PATIENTS SURVIVING AT LEAST 10 YEARS POST LIVER TRANSPLANTATION: LONG TERM RESULTS

M. Berenguer, A. Rubin, V. Aguilera, C. Sanchez-Montes, M. García-Eliz, C. Ortiz, F. Sanjuan, R. Lopez-Andujar, and M. Prieto; Valencia, Spain

 

                P-328     HEPATOPULMONARY SYNDROME IN CIRRHOTIC PATIENTS CANDIDATES TO A LIVER TRANSPLANTATION

Maria-Dolores Espinosa, Flor Nogueras, Carmen Olmedo, Rosa Macías, Karim Muffak-Granero, Ana Comino, Trinidad Villegas, Jose-Antonio Ramirez, Daniel Garrote, Pablo Bueno, and Jose-Antonio Ferron; Granada, Spain

 

                P-329     LIVER TRANSPLANT BILIARY MISMATCH: BILIARY TRANSPOSITION VS DUCTOPLASTY

Ian C. Carmody, Humberto Bohorquez, David Bruce, Ari Cohen, and George E. Loss; New Orleans, USA

 

                P-330     THE COMBINATION OF BOTH AICAR AND TMZ IN UW SOLUTION IS UNNECESSARY TO INCREASE SURVIVAL OF RECIPIENTS TRANSPLANTED WITH STEATOTIC LIVERS

Maria Elias-Miró, Mónica Jiménez-Castro, Araní Casillas-Ramirez, Marta Massip-Salcedo, Antoni Rimola, Juan Rodés, and Carmen Peralta; Barcelona, Spain

 

                P-331     EARLY AND EXTENDED THERAPY OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION

Felix García-Pajares, Gloria Sanchez Antolin, Carolina Almohalla, Rosa Conde, Carmen Ramos, Rafael Ruiz Zorrilla, Sara Lorenzo Pelayo, Rosario Velicia Llames, and Agustin Caro Paton; Valladolid, Spain

 

                P-332     USEFULNESS OF C4d DEPOSITS IN DIFFERENTIAL DIAGNOSIS BETWEEN ACUTE LIVER REJECTION AND HEPATITIS C RECURRENCE

Beata Gierej, and Barbara Górnicka; Warsaw, Poland

 

                P-333     WITHDRAW

 

                P-334     COMPARISON OF NORMAL SALINE AND LACTATED RINGER’S SOLUTION DURING LIVER TRANSPLANTATION

Sun-Ji Hyun, Hyo Jin Kim, Young Hee Shin, Justin Sangwook Ko, Mi Sook Gwak, Gaab Soo Kim, and Sung-Joo Kim; Seoul, Republic of Korea

 

                P-335     INFLUENCE OF CHOLESTASIS AND HEPATOCYTOLISIS ON LIVER STIFFNESS IN RECURRENT HEPATITIS C FOLLOWING LIVER TRANSPLANTATION

Speranta Iacob, Liana Gheorghe, Gabriel Becheanu, Mona Dumbrava, and Irinel Popescu; Bucharest, Romania

 

                P-336     METABOLIC DERANGEMENTS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION: THE PROBLEM INTO THE PROBLEM

Maddalena Iadevaia, Michela Giusto, Valerio Giannelli, Quirino Lai, Massimo Rossi, Stefano Ginanni Corradini, and Manuela Merli; Rom          e, Italy

 

                P-337     MICROVASCULAR RECONSTRUCTION OF HEPATIC ARTERY USING A NEW IMAGING DEVICE

Takuya Iida, Makoto Mihara, Mitsunaga Narushima, and Isao Koshima; Tokyo, Japan

 

                P-338     IMPACT OF LEFT LOBE GRAFT ON ADULT LIVING DONOR LIVER TRANSPLANTATION: SMALL-FOR-SIZE GRAFT IS NOT A RISK FACTOR FOR SHORT AND LONG OUTCOME

Satoru Imura, Mitsuo Shimada, Tohru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Michihito Asanoma, and Shinichiro Yamada; Tokushima, Japan

 

                P-339     WHEY PROTEIN ISOLATE, MEIN®, CAN REDUCE LIVER DAMAGE EARLY AFTER LIVING DONOR LIVER TRANSPLANTATION

Daichi Ishikawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Michihito Asanoma, Hisae Kume, and Hajime Sasaki; Tokushima, Japan; and Tokyo, Japan

 

                P-340     LATE ACUTE REJECTION MORE THAN 3 MONTHS AFTER LIVING AND DECEASED DONOR LIVER TRANSPLANTATION

Naoki Kawagishi, Ikuo Takeda, Shigehito Miyagi, Kazushige Satoh, Yorihiro Akamatsu, Satoshi Sekiguchi, and Susumu Satomi; Sendai, Miyagi, Japan

 

                P-341     USEFULNESS OF THE PINCH-BURN-CUT (PBC) TECHNIQUE WITH MONOPOLAR FORCEPS DURING TOTAL HEPATECTOMY OF THE RECIPIENTS IN LIVER TRANSPLANTATION

Bong-Wan Kim, Hee-Jung Wang, Myung-Wook Kim, Yong-Keun Park, and Weiguang Xu; Suwon, Korea

 

                P-342     LIVING DONOR LIVER TRANSPLANTATION: IMPACT ON DONOR’S HEALTH-RELATED QUALITY OF LIFE

Lampros Kousoulas, Nikos Emmanouilidis, Juergen Klempnauer, and Frank Lehner; Hannover, Germany

 

                P-343     PERIOPERATIVE ANTIMICROBIAL PROPHYLAXIS IN LIVER TRANSPLANT RECIPIENTS

Robert Król, Jacek Pawlicki, Joanna Badura, Jacek Ziaja, Tomasz Cierniak, and Lech Cierpka; Katowice, Poland

 

                P-344     INTRAOPERATIVE HEPATIC ARTERY BLOOD FLOW PREDICTS EARLY HEPATIC ARTERY THOMBOSIS AFTER LIVER TRANSPLANTATION

Luis M. Marín Gómez, Carmen Bernal Bellido, José M. Álamo Mártinez, Francisco M. Porras-López, Gonzalo Suárez-Artacho, Juan Serrano Diaz-Canedo, Javier Padillo Ruiz, and Miguel A. Gómez Bravo; Seville, Spain

 

                P-345     LONGTERM RENAL DYSFUNCTION IN LIVER TRANSPLANT RECIPIENTS

Mariana Mihaila, Alina Elena Tirdea, Laurentiu Micu, Irinel Popescu, and Mihai Voiculescu; Bucharest, Romania

 

                P-346     AMYLOID POLYNEUROPATHY RELAPSED 7 YEARS AFTER DOMINO TRANSPLANTATION WITH THE LIVER OF A 62-YEAR-OLD FAP DONOR

Kohei Miura, Yoshinobu Sato, Satoshi Yamamoto, Hiroshi Oya, Yoshiaki Hara, Takashi Kobayashi, Hidenaka Kokai, and Katsuyoshi Hatakeyama; Niigata, Japan

 

                P-347     PRE-TRANSPLANT PREDICTORS OF HEMODYNAMIC INSTABILITY AND NEED OF VENO-VENOUS BYPASS DURING LIVER TRANSPLANTATION

Bogdan Moldovan, Pascal Fauconnet, Eduardo Schiffer, Pietro E. Majno, Thierry Berney, Isabelle Morard, Emiliano Giostra, Philippe Morel, Gilles Mentha, and Christian Toso; Geneva, Switzerland

 

                P-348     CAVERNO-PORTAL ANASTOMOSIS TO RESTORE PORTAL FOW IN PATIENTS WITH PORTAL VEIN THROMBOSIS AND HEPATOPETAL CAVERNOMA UNDERGOING LIVER TRANSPLANTATION

Bogdan Moldovan, Gilles Mentha, Christian Toso, Philippe Morel, Marek Bednarkiewicz, Thierry Berney, Isabelle Morard, Sylvain Terraz, Emiliano Giostra, and Pietro E. Majno; Geneva, Switzerland

 

                P-349     THE POSSIBILITY OF ADIPOSE-DERIVED REGENERATIVE CELLS FOR AN ALTERNATIVE THERAPY FOR LIVER FAILURE

Hiroki Mori, Mitsuo Shimada, Yu Saito, Tohru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Shuichi Iwahashi, Michihito Asanoma, and Shinichiro Yamada; Tokushima, Japan

 

                P-350     LIVER TRANSPLANTATION FROM DCD DONORS – THE ROYAL FREE EXPERIENCE

Neal Banga, Prashant Naik, Dinesh Sharma, Charles Imber, Keith Rolles, Massimo Malago, Brian Davidson, and Bimbi Fernando; London, United Kingdom

 

                P-351     HEMOLYTIC ANEMIA DUE TO PASSENGER LYMPHOCYTE SYNDROME AFTER LIVER TRANSPLANTATION

Baltasar Pérez-Saborido, Asterio Barrera-Rebollo, David Pacheco-Sánchez, Pilar Pinto-Fuentes, Paloma Rodriguez-Vielba, Jose Carlos Sarmentero, Marta Gonzalo, Ruth Martinez, Mario Rodriguez, Carolina Almohalla, and Alfonso Anta; Valladolid, Spain

 

                P-352     GRAFT VERSUS HOST DISEASE AFTER LIVER TRANSPLANTATION, A RARE BUT SEVERE INMUNOLOGICAL COMPLICATION

Baltasar Pérez-Saborido, David Pacheco-Sánchez, Asterio Barrera-Rebollo, Pilar Pinto-Fuentes, Jose Carlos Sarmentero, Paloma Rodriguez-Vielba, Enrique Asensio, Fernando Labarga, Felix García-Pajares, Josee María Martínez, Elena Pérez, and Alfonso Anta; Valladolid, Spain

 

                P-353     LIVER TRANSPLANTATION AFTER RADIOEMBOLIZATION WITH YTTRIUM-90 MICROSPHERES

Sonia Radunz, Georgios C. Sotiropoulos, Jörg Schlaak, Andreas Bockisch, Thomas Lauenstein, Hideo A. Baba, Andreas Paul, and Jürgen W. Treckmann; Essen, Germany

 

                P-354     BUDD-CHIARI SYNDROME AS A INDICATION FOR LIVER TRANSPLANTATION

Piotr Remiszewski, Marcin Kotulski, Krzysztof Dudek, Piotr Kalinowski, Rafal Paluszkiewicz, Krzysztof Zieniewicz, and Marek Krawczyk; Warsaw, Poland

 

                P-355     ASSOCIATED FACTORS WITH THE TRANSFUSIONS NEEDS IN LIVER TRANSPLANTATION

Gloria Sanchez Antolin, Ignacio de la Fuente Graciani, Felix García-Pajares, Esther Fernandez, Carolina Almohalla, Judith Gil Dominguez, Angela Ruiz de Temiño, Lorena Sancho, Rafael Ruiz Zorrilla, and Agustin Caro Paton; Valladolid, Spain

 

                P-356     COAGULATION BETWEEN DONOR AND RECIPIENT IN THE EARLY PERIOD AFTER LIVING DONOR LIVER TRANSPLANTATION

Yoshinobu Sato, Satoshi Yamamoto, Hiroshi Oya, Yoshiaki Hara, Hidenaka Kokai, Takashi Kobayashi, Kohei Miura, and Katsuyoshi Hatakeyama; Niigata, Japan

 

                P-357     POST LIVER TRANSPLANT EVEROLIMUS BASED IMMUNOSUPPRESSION THERAPY: A MONO-CENTRIC EXPERIENCE

Vincenzo Scuderi, Giangiacomo Monti, Walter Santaniello, Francesco Sicoli, Antonio Giuliani, Carla Migliaccio, and Fulvio Calise; Naples, Italy

 

                P-358     ASSOCIATION BETWEEN PATENT FORAMEN OVALE ? ACUTE SUPERIOR MESENTERIC ARTERY OCCLUSION: IMPLICATIONS FOR INTESTINAL TRANSPLANTATION

Sushma Shankar, Mohammed Z. Akhtar, Oliver Ormerod, Anil Vaidya, Sanjay Sinha, and Peter Friend; Oxford, United Kingdom

 

                P-359     EFFECTS OF CALCINEURIN INHIBITOR-BASED IMMUNOSUPPRESSION ON PRE-EXISTING RENAL IMPAIRMENT FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION

Matthew P. Thomas, Jeremy J. French, Richard M. Charnley, Bryon C. Jaques, Steve A. White, and Derek M. Manas; Newcastle upon Tyne, United Kingdom

 

P-360     WITHDRAW

 

P-361     WITHDRAW

               

                P-362     SVR TO ANTIVIRAL TREATMENT FOR POST-OLT RECURRENT HCV HEPATITIS CAN BE IMPROVED BY THE USE OF GROWTH FACTORS

Vittoria Vero, Marco Senzolo, Luisa Pasulo, Francesca Romana Ponziani, Raffaella Vigano’, Maria Marino, Maria Francesca Donato, Maria Rendina, Pierluigi Toniutto, Matteo Cescon, Eleonora De Martin, Lucia Miglioresi, Valerio Giannelli, Daniele Di Paolo, Antonio Gasbarrini, and Stefano Fagiuoli; Rome, Italy; Padua, Italy; Bergamo, Italy; Milan, Italy; Modena, Italy; Bari, Italy; Udine, Italy; and Bologna, Italy

 

                P-363     THE PRESENCE OF DIABETES REDUCES SVR AFTER ANTIVIRAL THERAPY FOR POST-TRANSPLANT HCV RECCURRENCE

Vittoria Vero, Marco Senzolo, Pasulo Luisa, Francesca Romana Ponziani, Raffaella Viganò, Maria Marino, Maria Francesca Donato, Maria Rendina, Pierluigi Toniutto, Matteo Cescon, Eleonora De Martin, Lucia Miglioresi, Valerio Giannelli, Daniele Di Paolo, and Stefano Fagiuoli; Rome, Italy; Padua, Italy; Bergamo, Italy; Milan, Italy; Modena, Italy; Bari, Italy; Udine, Italy; and Bologna, Italy

 

                P-364     MULTIVISCERAL TRANSPLANTATION FOR MASSIVE ABDOMINAL TRAUMA

Chiara Zanfi, Augusto Lauro, Paolo Di Gioia, Sara Pellegrini, and Antonio D. Pinna; Bologna, Italy

 

Poster Session: Lung

                P-365     AN UNUSUAL CASE OF LUNG TRANSPLANTS AND BREAST IMPLANTS

Karthikan A. Srikanthan, Helen J. Ramsey, and Martin R. Carby; Harefield, Middlesex, United Kingdom

 

P-366     WITHDRAW

Poster Session: Pancreas

                P-367     BEWARE THE PANCREAS TRANSPLANT RECIPIENT WITH ELEVATED FIBRINOGEN AND HYPOTENSION

Thalis Christophides, John Asher, Emily Shrimpton, Duncan Watt, Jeremy French, Bryon Jaques, Derek Manas, Steve White, and David Talbot; Newcastle upon Tyne, United Kingdom

 

                P-368     ‘TIMING THE IMPLANT’: OUTCOMES IN PANCREAS TRANSPLANTATION

Gabriele Di Benedetto, David van Dellen, Melissa Oliveira Cunha, Maria O. Mitu-Pretorian, H. Zacaria, Abbas Ghazanfar, Bence Forgacs, Ravi Pararajasingam, Titus Augustine, and Afshin Tavakoli; Manchester, United Kingdom

 

                P-369     HHV-8 ASSOCIATED LYMPHADENOPATHIC KAPOSI’S SARCOMA MIMICKING PTLD AFTER PANCREAS TRANSPLANT

Yi-Ming Shyr, and Shin-E. Wang; Taipei, Taiwan

Poster Session: Pediatric transplantation

                P-370     PEDIATRIC LIVER-KIDNEY TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

Vittorio Corno, Alessandro Lucianetti, Paola Stroppa, Domenico Pinelli, Eliana Gotti, Michela Bravi, Giovanni Rota, Giuseppe Locatelli, Daniela Codazzi, Giuseppe Remuzzi, and Michele Colledan; Bergamo, Italy

 

                P-371     PEDIATRIC KIDNEY TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

Iris Fontana, Sergio Barocci, Fabrizio Ginevri, Gregorio Santori, Massimo Bertocchi, Augusto Tagliamacco, Arcangelo Nocera, and Umberto Valente; Genoa, Italy

 

                P-372     ABDOMINAL COMPARTMENT SYNDROME IN PEDIATRIC KIDNEY TRANSPLANTATION

Iris Fontana, Massimo Bertocchi, Monica Centanaro, Gregorio Santori, Francesca Rè, Teresa Cavallero, Fabrizio Ginevri, and Umberto Valente; Genoa, Italy

 

                P-373     LIVER RETRANSPLANTATION IN THE LONG TERM IN CHILDREN

Esteban Frauca, Loreto Hierro, Carmen Diaz-Fernandez, Angela de la Vega, Carmen Camarena, Gema Muñoz-Bartolo, Dolores Lledín, Manuel López-Santamaría, and Paloma Jara; Madrid, Spain

 

                P-374     FIRST EXPERIENCE WITH EVEROLIMUS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS

Dirk Nielsen, Andrea Briem-Richter, Marijke Sornsakrin, Lutz Fischer, Bjoern Nashan, and Rainer Ganschow; Hamburg, Germany

 

                P-375     ULTRASONOGRAPHY OF THE CAROTID WALL THICKNESS IN PEDIATRIC LIVER TRANSPLANT PATIENTS. OUR FINDINGS

Carlos E. Gonzalez Cambaceres, Yanina Camicer, María B. Araujo, Oscar Imventarza, Silvia Moguillansky, and María C. Mazza; Buenos Aires, Argentina

 

                P-376     QUALITY OF LIFE RELATED TO HEALTH: EXPERIENCE IN PEDIATRIC PATIENTS WITH CHRONIC DISEASES IN A PUBLIC HOSPITAL IN ARGENTINA

Carlos E. Gonzalez Cambaceres, Mariana Roizen, Carlos Figueroa, and Oscar Imventarza; Buenos Aires, Argentina

 

                P-377     LIVING DONOR LIVER TRANSPLANTATION FOR ACUTE LIVER FAILURE IN CHILDREN

Marek Szymczak, Piotr Kalicinski, Dorota Broniszczak, Joanna Teisseyre, Hor Ismail, and Joanna Pawlowska; Warsaw, Poland

 

                P-378     ESTABLISHMENT OF A PAEDIATRIC RENAL TRANSPLANT SERVICE IN TUNISIA

Mignon I. McCulloch, Anil Vaidya, Soussen Abroug, W. Sahtout, and Achour Abdellatif; London, United Kingdom; Oxford, United Kingdom; and Sousse, Tunisia

 

                P-379     SURGICAL COMPLICATIONS OF PEDIATRIC KIDNEY TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

Yugo Sawada, Hiroki Shirakawa, Hideki Ishida, Tomokazu Shimizu, and Kazunari Tanabe; Tokyo, Japan

 

                P-380     THE EFFECT OF ANTI CD-25 AB INDUCTION TREATMENT ON GRAFT FUNCTION IN THE ADOLESCENT KIDNEY TRANSPLANTATION FROM LIVE DONORS

Sait Murat Dogan, Ismail Sert, Cem Tugmen, Eyüp Kebabci, and Cezmi Karaca; izmir, Turkey

Poster Session: Tissue injury / preservation

                P-381     INNATE IMMUNE RESPONSES IN CORONARY ARTERY BYPASSES BY A NEW P38 MAPK-INHIBITOR

Dietmar K. Abendroth, Zhiwei Zhao, and Jianjun Ge; Ulm, Germany; and Hefei, China

 

                P-382     A NOVEL PERFUSION FLUID FOR DCD DONOR KIDNEYS; BETTER AS A FLUSH OR A STORAGE MEDIUM?

Christopher Ray, Muhammad Khurram, Omar Mownah, Aditya Kanwar, Susan Stamp, John Brassil, Douglas Rees, Kelly Philipson, Robert Peaston, Kathryn White, Katrina Wood, Aurelie Thomas, Anne Cunningham, Noel Carter, Paul Flecknell, and David Talbot; Newcastle upon Tyne, United Kingdom; and Sunderland, United Kingdom

 

                P-383     INFLUENCES OF THE DONOR TYPE ON ORGAN ENERGY STATUS: LIVING VERSUS BRAIN DEAD VERSUS NON-HEART BEATING DONOR

Philipp Stiegler, Michael Sereinigg, Vanessa Stadlbauer, Andreas Puntschart, Andrea Bradatsch, Pero Curcic, Thomas Seifert-Held, Tatjana Stojakovic, Barbara Leopold, Daniela Blattl, Ursula Mayrhauser, Bettina Leber, Sonja Köstenbauer, Seth Hallström, and Karlheinz Tscheliessnigg; Graz, Austria

 

 

Late breaking

LB-P-001               ORGAN DONATION AFTER THERAPEUTIC NEPHRECTOMY

Colin H. Wilson, David A. Rix, Neil S. Sheerin, David Talbot, Derek M. Manas.; Newcastle-upon-Tyne, United Kingdom

 

LB-P-002               STILAMIN IN THE TREATMENT OF LYMPHATIC FISTULA AFTER LIVING-RELATED RENAL TRANSPLANTATION

                                Libo Xie, Shaofeng He, Zhongli Huang, Tao Lin.; Chengdu, China

 

LB-P-003               THE EFFECTIVENESS OF THE MOVING TO MORPHINE AUGMENTED MAGNETIC RESONANCE CHOLANGIOPANCREATICOGRAPHY FOR IMPROVING THE QUALITY OF IMAGES IN LIVING LIVER DONORS

Doo Jin Kim, Gyu-seong Choi, Hyung-chul Kim, Samuel Lee, Joo Seop Kim.; Seoul, Korea; Bucheon, Korea

 

LB-P-004               IN SITU SPLITTING USING A DONOR WITH AN INTRA-AORTIC BALLOON PUMP

Anya Adair, Khalid Sharif, Sara Gozzini, John Isaac, Paolo Muiesan.; Birmingham, United Kingdom

 

LB-P-005               ALTERNATIVE PORTO-LEFT GASTRIC VEIN ANASTOMOSIS WITH OVARIAN VEIN GRAFT INTERPOSITION IN POST KASAI EXTRAHEPATIC PORTAL VEIN OBSTRUCTION

                                Mureo Kasahara, Seisuke Sakamoto, Akinari Fukuda, Hiroyuki Kanazawa.; Tokyo, Japan

 

LB-P-006               ADULT RIGHT LOBE LIVE DONOR LIVER TRANSPLANTATION (LDLT) IN PRESENCE OF A RETRO-PORTAL ACCESSORY RIGHT HEPATIC ARTERY (RPARHA) ARISING FROM LEFT HEPATIC ARTERY (LHA)

M.T.P.R. Perera, J.R. Isaac, S.R. Bramhall, A.D. Mayer, D.F. Mirza, P. Muiesan.; Birmingham, United Kingdom

 

LB-P-007               PASSIVE TRANSFER OF PEANUT ALLERGY BY ORGANS TRANSPLANTATION

Hervé Creusvaux, Marina Roche, Armelle Boulvard, Annick Andre, Claudie Mouton-Faivre, Pascale Dewachter.; Saint-Denis la Plaine, France; Nancy, France; Clermont-Ferrand, France

 

LB-P-008               DEVELOPMENT AND IN VITRO EVALUATION OF CLINICALLY APPLICABLE MICRON-SIZED SILICA-BASED IRON OXIDE PARTICLES FOR CELLULAR IMAGING WITH MRI

Carolin M. Langer, Nathanael Raschzok, Martina Mogl, Susanne Rohn, Kerstin Nehls, Christian Schmidt, Lars Stelter, Lutz Lüdemann, Ulf Teichgräber, Igor M. Sauer.; Berlin, Germany

 

LB-P-009               ROLES OF TOLL-LIKE RECEPTORS IN ALLOGENEIC ISLET TRANSPLANTATION

                                Myung-Kyu Kim, Han Ro, Ju Ho Hong, Curie Ahn, Jaeseok Yang.; Seoul, Republic of Korea

 

LB-P-010               MRI ENABLES NON-INVASIVE MONITORING DURING LIVER CELL TRANSPLANTATION TO THE SPLEEN IN A PORCINE MODEL

Nathanael Raschzok, Jens Pinkernelle, Nils Billecke, Kerstin Nehls, Martina T. Mogl, Maciej Powerski, Ulf Teichgräber, Igor M. Sauer.; Berlin, Germany; Jena, Germany

 

LB-P-011               NEOHYBRID LIVER GRAFT [ndash] A NOVEL CONCEPT OF IN VIVO TISSUE-ENGINEERING

Martina T. Mogl, Susanne Rohn, Nathanael Raschzok, Birgit Sawitzki, Igor M. Sauer.; Berlin, Germany

 

LB-P-012               ISLET AFTER KIDNEY TRANSPLANTATION AND POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE

Paola Maffi, Rossana Caldara, Marina Scavini, Lorenzo Piemonti, Paola Magistretti, Carlo Socci, Maurilio Ponzoni, Fabio Ciceri, Antonio Secchi.; Milano, Italy

 

LB-P-013               ESTABLISHING THE SNBTS ISLET ISOLATION LABORATORY

Lindsay Fraser, Donna L. Mitchell, Alan P. Timpson, Peter F. Henry, Lora McCracken, Tom McQuillan, John Drain, George Galea, Neil McGowan.; Edinburgh, United Kingdom

 

LB-P-014               HLA-A,B,DR ALLELE FREQUENCIES AND MATCHING ALGORITHM IN CADAVERIC KIDNEY TRANSPLANTATION PAIRS

Renata Zunec, Zorana Grubic, Nikolina Basic-Jukic, Ljubica Bubic Filipi, Zeljko Kastelan, Josip Pasini, Jasna Stoic-Brezak.; Zagreb, Croatia

 

LB-P-015               [ldquo]CALCULATED RISK[rdquo] DONOR RELATED SOLID ORGAN TRANSPLANTATIONS IN THE EMILIA-ROMAGNA REGION (ERR) (2003-2009): ANALYSIS OF GRAFT SURVIVAL

Carlo De Cillia, Nicola Alvaro, Giacomo Caprara, Deborah Malvi, Walter F. Grigioni, Lorenza Ridolfi.; Bologna, Italy

 

LB-P-016               IMFLUENCE OF THE RATIO OF GRAFT VOLUME TO RECIPIENT BODY SURFACE AREA ON GRAFT FUNCTION AFTER LIVING DONOR KIDNEY TRANSPLANTATION

                                Jong Hoon Lee, Je Hwan Won, Chang-Kwon Oh.; Suwon, Republic of Korea

 

LB-P-017               LEVEL AND SOURCES OF INFORMATION ON ORGAN TRANSPLANTATION IN ROMANIA

Beatrice Ioan, Cristina Gavriluta, Andrei Holman, Mihaela Frunza, Irina Streba, Adina Karner-Hutuleac, Roxana Zavoi, Lacrima Boila.; Iasi, Romania; Cluj, Romania; Iasi, Romania; Craiova, Romania; Tirgu Mures, Romania

 

LB-P-018               EVALUATING AN ORGAN DONATION TEACHING RESOURCE FOR SECONDARY SCHOOLS IN SCOTLAND

Neil Healy, Lesley Logan, Pamela Niven, Elizabeth Burchell.; Falkirk, United Kingdom; Edinburgh, United Kingdom

 

LB-P-019               ADAPTIVE TRIAL DESIGN FOR IMMUNE TARGETING BIOLOGICS [ndash] A CREATIVE AND COOPERATIVE APPROACH TO ADVANCING TRANSPLANT MEDICINE

Ellen Cooper, Meghann Teague Getts, Terra J. Frederick, James J. Herrmann, John Puisis, Daniel R. Getts, Stuart M. Flechner.; Kalamazoo, USA; Rockville, USA; Chicago, USA; Cleveland, USA

 

LB-P-020               DOES VAMS DONOR NEPHRECTOMY SATISFY DONORS IN BODY IMAGES?

Man Ki Ju, Hyei Mi Yang, Seung Hwan Lee, Chang Hee Hong, Sun Young Sohn.; Seoul, Korea

 

LB-P-021               TOOLS OF ENGAGEMENT WITH YOUNG ADULTS IN RENAL: FINDING FROM YOUNG ADULT PROJECT IN SOUTH WEST ENGLAND

                                Joanna M. Woodland, Sally Tutton.; Bristol, United Kingdom

 

LB-P-022               CERTIFICATION OF ORGAN AND TISSUE PROCUREMENT ORGANISATIONS: THE FRENCH EXPERIENCE

Hervé Creusvaux, Eric Auger, Nasser Al Hawajri, Anita Guarinos.; Saint Denis la Plaine, France

 

LB-P-023               PHARMACOKINETICS OF TACROLIMUS MODIFIED RELEASE QD FOLLOWING LIVING DONOR LIVER TRANSPLANTATION: RESULTS OF PILOT STUDY

Gi-Won Song, Sung-Gyu Lee, Jung-Man Namgung, Chun-Soo Park, Hyo-Jun Lee, Won-Young Chae, Hee-Sung Park.; Seoul, Korea

 

LB-P-024               DETERMINANTS OF SUCCESSFUL USE OF SIROLIMUS IN RENAL TRANSPLANTATION

Wilfried Gwinner, Wolfgang Arns, Klemens Budde, Fritz Diekmann, Frank Eitner, Michael Fischereder, Jan Goßmann, Nils Heyne, Marcel G. Naik, Christian Morath, Katharina Pressmar, Jan-Steffen Juergensen.; Hannover, Germany; Cologne, Germany; Berlin, Germany

 

LB-P-025               A THERAPEUTIC EXPLORATORY STUDY TO DETERMINE THE EFFICACY AND SAFETY OF CALCINEURIN-INHIBITOR-FREE DE-NOVO IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION (CILT): THE INTERIM ANALYSIS

Armin D. Goralczyk, Wijdan Abu-Ajaj, Giuliano Ramadori, Thomas Lorf, Aiman Obed.; Goettingen, Germany

 

LB-P-026               EFFECT OF INTERLEUKIN 2 RECEPTOR ANTIBODY BASILIXIMAB (IL[sub]2[/sub]RA) IN TACROLIMUS (TAC) BASED IMMUNOSUPPRESSION WITH AZATHIOPRINE (AZA)/ MYCOPHENOLATE MOFETIL (MMF) IN LIVING DONOR KIDNEY TRANSPLANT PROGRAMME

S. Jain, P. N. Gupta, S. Pokhariyal, S. B. Bansal, V. Saxena, R. Sharma, M. Singhal, S. Gulati, R. Ahlawat, V. Kher.; Gurgaon, India; New Delhi, India; Noida, India

 

LB-P-027               THE RELATION BETWEEN TESTOSTERONE LEVELS AND GRAFT FUNCTION IN KIDNEY RECIPIENTS UNDER TREATMENT OF m-TOR OR CALCINEURIN INHIBITOR

                                Hulya Colak, Tufan Colak, Yusuf Kurtulmus, Ismail Sert, Cezmi Karaca.; Izmir, Turkey

 

LB-P-028               CYTOKERATIN DEPLETION IN PROXIMAL TUBULES OF NEPHRONS CORRELATES WITH OXIDATIVE STRESS INDICES IN RATS ON IMMUNOSUPPRESSION

Karolina Kedzierska, Miroslaw Parafiniuk, Katarzyna Sporniak-Tutak, Joanna Bober, Maria Laszczynska, Kazimierz Ciechanowski.; Szczecin, Poland

 

LB-P-029               DESENSITIZATION RESULTS ARE INFLUENCED BY THE NATURE OF THE HLA Ab BEING TREATED

E. Steve Woodle, Alin Girnita, Paul Brailey, Basma Sadaka, Adele Rike-Shields, Rita R. Alloway, Garth Wall.; Cincinnati, USA

 

LB-P-030               ELEVATION OF LBP AFTER LIVER ISCHEMIA AND REPERFUSION INJURY IN RATS

Haoshu Fang, Anding Liu, Olaf Dirsch, Uta Dahmen.; Jena, Germany; Essen, Germany; Jena, Germany

 

LB-P-031               FK506 INDUCES APOPTOSIS OF HUMAN JURKAT T CELLS THROUGH MITOCHONDRIA AND DEATH RECEPTOR RELATED SIGNALING PATHWAYS

                                Jong Hun Park, Ho Kyun Lee, Sang Young Chung, Soo Jin Na Choi.; Gwangju, Korea

 

LB-P-032               THE EXPRESSION OF MicroRNA TREATED TACROLIMUS (FK506) IN JURKAT HUMAN T LYMPOCYTES

                                Ho Kyun Lee, Jon Hun Park, Sang Young Chung, Soo Jin Na Choi.; Gwangju, Korea

 

LB-P-033               PROTECTIVE EFFECT OF NOVEL mTOR INHIBITORS ON HUMAN PRIMARY CELLS UNDER OXIDATIVE STRESS

Vladimira Moulisova, Claire Brown, Paul Shiels.; Glasgow, United Kingdom; Alderley Park, United Kingdom

 

LB-P-034               QUANTITATIVE STRENGTH OF ANTIOXIDANTS IS MORE ESSENTIAL FOR THE TREATMENT OF ISCHEMIA REPERFUSION INJUY OF SOLID ORGAN TRNASPLANTATION

                                Ik Jin Yun.; Seoul, Korea

 

LB-P-035               MYCOPHENILIC ACID MEDIATED MITOCHONDRIAL MEMBRANE POTENTIAL TRANSITION CHANGE LEAD TO T LYMPHOCYTE APOPTOSIS

                                Sang Young Chung, Soo Jin Na Choi.; Gwangju, Korea

 

LB-P-036               TRANSCRIPTIONAL ACTIVATION OF NUCLEAR RELATED FACTOR 2 (Nrf 2) BY FK506 IN JURKAT CELLS

                                Sang Young Chung, Soo Jin Na Choi.; Gwangju, Korea

 

LB-P-037               PROTECTIVE MECHANISM OF HEME OXYGENASE-1 ON MPA-INDUCED APOPTOSIS IN HUMAN JURKAT CELLS

                                Sang Young Chung, Ho Kyun Lee, Jong Hun Park, Soo Jin Na Choi.; Gwangju, Korea

 

LB-P-038               EFFECT OF FK506 ON ENDOPLASMIC RETICULUM (ER)-MEDIATED APOPTOSIS OF JURKAT CELLS

                                Sang Young Chung, Ho Kyun Lee, Jong Hun Park, Soo Jin Na Choi.; Gwangju, Korea

 

LB-P-039               BIOMARKERS IN URINE AFTER KIDNEY TRANSPLANTATION: NON-INVASIVE MONITORING OF ACUTE REJECTION

Zuzana Zilinska, Helena Bandzuchova, Daniel Kuba, Martin Chrastina, Jan Breza, Erika Bilcikova.; Bratislava, Slovakia (Slovak Republic)

 

LB-P-040               HMGB1 TRANSLOCATION AND EXPRESSION IS CAUSED BY WARM ISCHEMIA REPERFUSION INJURY, BUT NOT BY PARTIAL HEPATECTOMY IN RATS

Anding Liu, Haoshu Fang, Olaf Dirsch, Wei Dong, Hao Jin, Hai Huang, Uta Dahmen.; Jena, Germany; Essen, Germany; Shaoxing, China; Jena, Germany

 

LB-P-041               CLINICAL RELEVANCE OF HLA-DONOR SPECIFIC ANTIBODIES DETECTED BY SINGLE ANTIGEN ASSAY IN CARDIOTHORACIC TRANSPLANTATION

Derrick Rowan, Arun Gupta, Daniel McCloskey, Michael Burch, Matthew Fenton, Paul Sinnott.; London, United Kingdom

 

LB-P-042               TESTOSTERONE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS ON TOP OF BISPHOSPHONATE THERAPY EXERTS MULTIPLE BENEFITS ON BONE MASS, LIBIDO AND SEXUAL ACTIVITY

Doris Wagner, Harald Dobnig, KarlHeinz Tscheliessnigg, Günther Prenner, Andrä Wasler, Claudia Piswagner-Sölkner, Daniela Kniepeiss, Astrid Fahrleinter.; Graz, Austria

 

LB-P-043               PAEDIATRIC PROCUREMENT IN FRANCE: 2001 [ndash] 2010

                                François-Xavier Lamy, Christian Lamotte, Véronique Reiter-Chenel.; Saint-Denis, France

 

LB-P-044               THE RATE OF DISCARD OF KIDNEYS RECOVERED FOR TRANSPLANTATION IN THE UNITED STATES IS NOT JUSTIFIED

                                Francis L. Delmonico.; Waltham, USA

               

LB-P-045               DONOR ACTION PROGRAM IN THE EMILIA-ROMAGNA REGION (ERR): RESULTS

                                Carlo De Cillia, Maria C. Bonanno, Tiziana Campione, Lorenza Ridolfi.; Bologna, Italy

 

LB-P-046               IMPLEMENTATION OF A TISSUE PROCUREMENT MULTIDISCIPLINARY FUNCTIONAL PLAN IN A UNIVERSITY HOSPITAL IN SPAIN

Alberto Sandiumenge, Virginia Callao, Eduardo Gonzalez, Mari Gilavert, Laia Ramiro, Enric Contreras, Maria Bodi.; Tarragona, Spain; Tarragona i Terres del Ebre, Spain

 

LB-P-047               EMRS [ndash] UNINTENDED CONSEQUENCE SAVINGS

                                Andrew Inglis, Paul Campbell, Deborah Hill.; Glasgow, United Kingdom

 

LB-P-048               A MULTIDISCIPLINARY PROTOCOL FOR THE MANAGEMENT OF PEDIATRIC POTENTIAL HBD

Roberto Peressutti, Adriana Di Silvestre, Annalisa Sostero, Alessandra Berini, Elisa Mattiussi.; Udine, Italy

 

LB-P-049               AN AUDIT PROCESS FOR THE IMPLEMENTATION OF A PROTOCOL FOR THE MANAGEMENT OF POTENTIAL ORGAN DONORS IN INTENSIVE CARE UNIT

Roberto Peressutti, Adriana Di Silvestre, Annalisa Sostero, Alessandra Berini, Elisa Mattiussi.; Udine, Italy

 

LB-P-050               ENDOUROLOGICAL MANAGEMENT OF UROLITHIASIS IN DONOR KIDNEYS PRIOR TO RENAL TRANSPLANT

Muhammad T. Dosani, Johm Moir, Nikhil Vasdev, David Talbot, David Rix.; Newcastle upon Tyne, United Kingdom

 

LB-P-051               BROSELOW SYSTEM IN THE MANAGEMENT OF PEDIATRIC ORGAN DONOR

                                Roberto Peressutti, Paola De Stefanis, Adriana Di Silvestre, Elisa Mattiussi.; Udine, Italy

 

LB-P-052               STAFF OPINIONS ON ORGAN DONATION IN A DISTRICT GENERAL HOSPITAL

Charlotte K. Gunner, Liz Waite, Jacques Kerr.; Melrose, United Kingdom; Edinburgh, United Kingdom; Melrose, United Kingdom

 

LB-P-053               NATIONAL EVALUATION OF HEPATITIS B CORE ANTIBODY-POSITIVE DONORS IN FRANCE

François-Xavier Lamy, Fabienne Pessione, Hervé Creusvaux, Marina Roche, Marie Thuong; Saint Denis - la Plaine, France

 

LB-P-054               FULLY AUTOMATED GENERATION OF ANTIGEN-SPECIFIC CD4+ AND CD8+ T CELLS FOR ADOPTIVE IMMUNOTHERAPY

Melanie Fahrendorff, Nanette von Oppen, Georg Rauser, Mario Assenmacher, Martin Biehl, Stefan Miltenyi; Bergisch-Gladbach, Germany

 

LB-P-055               HIGH PREVALENCE OF MULTIRESISTANT GRAM NEGATIVE BACTERIA IN RENAL TRANSPLANT PATIENTS

Ieva Ziedina, Elina Dimina, Dace Vensava-Kaknena, Arta Balode, Janis Jushinskis, Rafail Rozental, Uga Dumpis; Riga, Latvia

 

LB-P-056               MicroRNA REGULATION OF CELLULAR BIO-AGE PROVIDES A NOVEL PRE-TRANSPLANT PROGNOSTIC AND PREDICTIVE ASSESSMENT OF POST TRANSPLANT ALLOGRAFT FUNCTION

Dagmara McGuinness, Marc Gingell-Littlejohn, Karen Stevenson, David Kingsmore, Marc Clancy, Paul G. Shiels; Glasgow, United Kingdom

 

LB-P-057               LIVING DONOR KIDNEY TRANSPLANTATION IN T-CELL FLOW CYTOMETRY CROSS-MATCH POSITIVE PATIENTS AFTER DESENSITIZATION WITHOUT INTRAVENOUS IMMUNOGLOBULIN

Jae Berm Park, Young Hoon Kim, Ki Byung Song, Young Soo Chung, Joo Hee Jung, Heung-Bum Oh, Seog-Woon Kwon, Su Kil Park, Song-Cheol Kim, Duck Jong Han; Seoul, Republic of Korea

 

LB-P-058               STUDY OF SERUM ACTIVIN AND FOLLISTATIN IN POST RENAL TRANSPLANT PATIENTS: CORRELATION WITH RENAL HAEMODYNAMICS, GRAFT FUNCTION AND SURVIVAL

                                Hayam A. El Aggan, Sabah A. Mahmoud, Osama H. Shehata; Alexandria, Egypt

 

LB-P-059               THE GENETIC VARIANTS OF [italic]IL1R1[/italic] AND [italic]IL1RN[/italic] ARE ASSOCIATED WITH THE DEVELOPMENT OF ACUTE REJECTION IN KIDNEY TRANSPLANTATION

                                Seok Ju Park, Yeong Hoon Kim, Young Chul Yoon, Sun Woo Kang, Tae Hee Kim; Busan, Korea

 

LB-P-060               SLOW GRAFT FUNCTION IN LIVING DONOR KIDNEY TRANSPLANTATION: AN ISSUE TO BE ADDRESSED

Joyce Hellegering, Jetze Visser, Heinrich J. Kloke, Frank C.H. d'Ancona, Andries J. Hoitsma, Daan J.A. van der Vliet, Michiel C. Warlé; Nijmegen, the Netherlands

 

LB-P-061               THE FATE OF RENAL RECIPIENTS WITH PRETRANSPLANT MALIGNIENCIES

Luisa Berardinelli, Raiteri Mauro, Carini Monica, Marenghi Cristina, Campise Maria Rosaria, Rossetti Antonello; Milan, Italy

 

LB-P-062               THE VALUE OF RENAL VASCULAR RESISTIVE INDEX MEASUREMENT AFTER RENAL TRANSPLANTATION

Line Heylen, Kathleen Claes, Christophe Metalidis, Hylke de Jonge, Liesbeth De Wever, Filip Claus, Raymond Oyen, Dirk Kuypers, Maarten Naesens; Leuven, Belgium

 

LB-P-063               EARLY POST-TRANSPLANT MAG3 RENAL SCAN PREDICTS LONG-TERM OUTCOME OF RENAL TRANSPLANTS

Ui Jun Park, Hyoung Tae Kim, Won Hyun Cho, Eun Ae Kim, Min Young Kim, Eun A. Hwang, Sung Yeup Han, Sung Bae Park, Hyun Chul Kim; Daegu, Korea

 

LB-P-064               MAGNETIC RESONANCE (MR) VENOGRAPHY AND MR UROGRAPHY IN KIDNEY DONOR ASSESSMENT [ndash] CORRELATION WITH OPERATIVE FINDINGS

Emma L. Aitken, Reddi P. Yadaval, Ram Kasthuri, S. Chandramohan, Giles Roditi, Marc Clancy; Glasgow, United Kingdom

 

LB-P-065               TRANSPLANTATION OF RIGHT LIVING DONOR KIDNEYS IN OBESE RECIPIENTS CORRELATES WITH A DECREASED GRAFT SURVIVAL

Joyce Hellegering, Jetze Visser, Frank C.H. d'Ancona, Hans J.F. Langenhuijsen, Andries J. Hoistma, Daan J.A. van der Vliet, Michiel C. Warlé; Nijmegen, the Netherlands

 

LB-P-066               COMPARISON OF HEART RATE VARIABILITY BETWEEN PATIENTS ON KIDNEY TRANSPLANTATION AND HEMODIALYSIS

                                Joon Seok Oh, Kill Huh, Jong In Park, Jong Hyun Park, Young Il Choi; Busan, Korea

 

LB-P-067               ASSOCIATIONS BETWEEN MMP-2 GENE POLYMORPHISMS AND POST-TRANSPLANTATIONAL DIABETES MELLITUS IN KOREAN RENAL ALLOGRAFT RECIPIENTS

Sun Woo Kang, Seok Ju Park, Tae Hee Kim, Yeong-Hoon Kim, Kyung-Hwan Jeong, Joo-Young Moon, Sang-Ho Lee, Tae-Won Lee, Chun-Gyoo Ihm; Busan, Republic of Korea; Seoul, Republic of Korea

 

LB-P-068               PROTEINURIA AND RENAL FUNCTION PREDICT OUTCOME AFTER LATE INITIATION OF SIROLIMUS IN RENAL ALLOGRAFT RECIPIENTS

K. Budde, M. G. Naik, W. Arns, F. Diekmann, M. Fischereder, J. Goßmann, W. Gwinner, N. Heyne, J. S. Jürgensen, C. Morath, K. Pressmar, F. Eitner; Berlin, Germany

 

LB-P-069               INTERLEUKIN 2 (IL2) RECEPTOR ANTAGONIST INDUCTION DRAMATICALLY IMPROVES ECD KIDNEY TRANSPLANTATION RESULTS

Kristian Heldal, Anders Hartmann, Torbjørn Leivestad, Anna V. Reisæter, Axel Foss, Karsten Midtvedt; Skien, Norway; Oslo, Norway

 

LB-P-070               CHALLENGING THE OLD TRADITIONS IN RENAL TRANSPLANTATION: ENHANCED RECOVERY AFTER RENAL TRANSPLANTATION

Ahmed Halawa, Simon Boyes, Fleur Roberts, Rebecca Palmer, Rory McGoldrick; Sheffield, United Kingdom

 

LB-P-071               IMPROVING ACCESS TO PRE-EMPTIVE KIDNEY TRANSPLANTATION IN ENGLAND: A NATIONAL QUALITY IMPROVEMENT PROGRAM

                                Bev Matthews, Ben Bray, Donal O'Donoghue; London, United Kingdom

 

LB-P-072               THE QUALITY OF REFERENCE COSTS FOR KIDNEY TRANSPLANTATION

Ben Bray, Julie Renfrew, Bev Matthews, Donal O'Donoghue; Nationwide, United Kingdom; London, United Kingdom

 

LB-P-073               INCIDENCE AND RISK FACTORS IN NEW ONSET DIABETES MELLITUS AFTER KIDNEY TRANSPLANT AND SIMULTANEOUS PANCREAS KIDNEY TRANSPLANT

Pérez-Sáez María José, Agüera María Luisa, Toledo Katia, Redondo María Dolores, Navarro María Dolores, Rodríguez-Benot Alberto, Aljama Pedro; Còrdoba, Spain

 

LB-P-074               ABO INCOMPATIBLE LIVING DONOR TRANSPLANTATION (ABOI KT): MINIMAL DOSE OF RITUXIMAB AND NOT A ROUTINE BUT AS NEEDED POSTTRANSPLANT PLASMAPHERESIS

                                Jin M. Kong, Joon H. Jeong, Byung C. Kim, Mi Y. Jeon; Busan, Korea

 

LB-P-075               THE INFLUENCE OF OBESITY ON RENAL TRANSPLANT OUTCOMES A PAIRED KIDNEYS ANALYSIS

                                Zuzanna Wolyniec, Alicja Debska-Slizien, Boleslaw Rutkowski; Gdansk, Poland

 

LB-P-076               ROBOT-ASSISTED LIVE KIDNEY DONATION: THE ROTTERDAM EXPERIENCE

S.M. Hagen, L.F.C. Dols, T. Terkivatan, F.J.M.F. Dor, T.C.K. Tran, J.N.M. IJzermans; Rotterdam, the Netherlands

 

LB-P-077               BONE DISEASE AND VERTEBRAL FRACTURES AFTER KIDNEY TRANSPLANTATION

Valentina Nastasi, Domenica Taruscia, Gloria Manarini, Giovanni Gaffi, Giovanni Maria Frascà; Ancona, Italy

 

LB-P-078               THE EFFECTIVENESS OF LOW DOSE DACLIZUMAB COMPARED WITH STANDARD REGIMEN IN PREVENTING FOR ACUTE REJECTION PREVENTION AFTER RENAL TRANSPLANTATION IN KERMAN-IRAN

Jalal Azmandian, Seyed Mojtaba Sohrevardi, Zahra Shafiee; Kerman, Islamic Republic of Iran

 

LB-P-079               LOWER DOSE OF MYCOPHENOLATE MOFETIL IS ENOUGH FOR RITUXIMAB TREATED RENAL TRANPLANT PATIENTS

Chung Hee Baek, Kyung Sun Park, Duck Jong Han, Jae Berm Park, Tae Young Kim, Su-Kil Park; Seoul, Korea

 

LB-P-080               THE PORCINE EXPERIMENTAL MODEL OF HETEROTOPIC RENAL AUTO-TRANSPLANTION

                                Alice Faure, Charlotte Maurin, Eric Lechevallier, Christian Coulange; Marseille, France

 

LB-P-081               PARVOVIRUS B 19 INDUCED ANEMIA IN RENAL TRANSPLATATION: EXPERIENCE OF ASAN MEDICAL CENTER

Ki Byung Song, Duck Jong Han, Song Cheol Kim, Jae Berm Park, Young Hoon Kim, Young Soo Chung; Songpa-ku, Republic of Korea

 

LB-P-082               EXPECTED RELATIONSHIP CHANGES INFLUENCE DECISION MAKING AROUND LIVING KIDNEY TRANSPLANTATION

Ingrid I.B. de Groot, Karen K. Schipper, Sandra S. Van Dijk, Paul P.J.M. Van der Boog, Andre A.G. Baranski, Perla P.J. Marang-van de Mheen; Leiden, the Netherlands; Amsterdam, the Netherlands; Leiden, the Netherlands

 

LB-P-083               EFFECTIVENESS OF PREOPERATIVE HYDROSTATIC DILATATION OF CONTRACTED BLADDER FOR KIDNEY TRANSPLANTATION

                                Jong Po Kim, Jin Min Kong, Joon Heon Jeong; Busan, Korea

 

LB-P-084               SUPPORTING YOUNG ADULTS WITH CHRONIC KIDNEY DISEASE [ndash] BASELINE SERVICE DATA

Matthew Tomlin, Heather Langham, Emma Coyne, Wendy Hope, Beverley Matthews, Donal O'Donoghue, Charlotte Bebb, Catherine Byrne, Cathy Johnson; Nottingham, United Kingdom; Derby, United Kingdom; East Midlands, United Kingdom; London, United Kingdom

 

LB-P-085               OUTCOME OF KIDNEY TRANSPLANTATION FROM ELDERLY DONORS (60 YRS AND ABOVE) [ndash] SINGLE CENTRE EXPERIENCE

                                Ahmed Halawa, A.O. Adekoya, A.M. El Nahas; Sheffield, United Kingdom

 

LB-P-086               MOVING OF RIGHT ILIAC VEIN AND SHORT RENAL VEIN IN LIVING DONOR KIDNEY TRANSPLANTATION

                                Thu Thi Ngoc Du, Sinh Ngoc Tran; Ho Chi Minh City, Viet Nam

 

LB-P-087               MONITORING OF STABLE RENAL ALLOGRAFTS IN EARLY POST-TRANSPLANT PERIOD: CAN THE SERUM CREATININE AND GLOMERULAR FILTRATION RATE MEASUREMENT REPLACE THE SEQUENTIAL PROTOCOL BIOPSY?

Karel Krejcí, Tomáš Tichý, Hana Ciferská, Pavel Horák, Andrea Smrzová, Miroslav Hrubý, Kamil Zamboch, Petr Bachleda, Josef Zadrazil; Olomouc, Czech Republic

 

LB-P-088               EXPLORING THE NEEDS OF YOUNG ADULTS WITH CHRONIC KIDNEY DISEASE

Heather Langham, Emma Coyne, Matthew Tomlin, Beverley Matthews, Donal O'Donoghue, Charlotte Bebb, Cathy Johnson, Wendy Hope, Catherine Byrne; Nottingham, United Kingdom; Derby, United Kingdom; East Midlands, United Kingdom; London, United Kingdom

 

LB-P-089               CLINICAL VALUE OF PREOPERATIVE CORONARY RISK ASSESSMENT WITH COMPUTED TOMOGRAPHY CORONARY ARTERIOGRAPHY FOR ADULT LIVING DONOR LIVER TRANSPLANTATION

Won-young Chae, Shin Hwang, Gi-Won Song, Gil-Chun Park, Jung-Man Namgoong, Jae-Jung Kim, Gyu-Sam Hwang; Seoul, Korea

 

LB-P-090               THE EFFECTIVENESS OF PLASMAPHERESIS AS A LIVER SUPPORT FOR LIVER GRAFT DYSFUNCTION FOLLOWING ADULT LIVING DONOR LIVER TRANSPLANTATION

                                Cheon-Soo Park, Shin Hwang, Hyeong-Woo Park, Seog-Woon Kwon, Sung-Gyu Lee; Seoul, Korea

 

LB-P-091               TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) AFTER LIVER TRANSPLANTATION (LT): VASCULAR COMPLICATIONS (VC) CONSTITUTE A GOOD INDICATION

Marco Senzolo, Giulia Magini, Andrew Burroughs, Michele Colledan, Giacomo Zanus, Stefano Fagiuoli; Padua, Italy; Bergamo, Italy; London, United Kingdom; Padua, Italy

 

LB-P-092               TRANSESOPHAPHAGEAL ECHOCARDIOGRAPHY DURING ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH ESOPHAGEAL VARICES

Maximilian Thum, Remy Schwarzer, Rastko Karatosic, Ursula Burger-Klepp, Valentin Fuhrmann, Gabriela Berlakovich, Andreas Bacher, Peter Faybik; Vienna, Austria

 

LB-P-093               DE NOVO MALIGNANCY IN LIVER TRANSPLANT RECIPIENTS

                                Hyeong-Woo Park, Sung-Gyu Lee, Shin Hwang, Ki-Hun Kim, Cheon-Soo Park; Seoul, Korea

 

LB-P-094               DIFFERENCE OF REGENERATION POWER BETWEEN HEALTHY AND DISEASED LIVER

                                Man Ki Ju, Gi Hong Choi, Joon Sung Park, Dong Sub Yoon; Seoul, Korea

 

LB-P-095               CHARACTERIZATION OF HEPATOCYTE-LIKE CELLS FROM HUMAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS ON A NOVEL HEPATOGENIC MEDIA

Maryam Ayatollahi, Masoud Soleimani, Bita Geramizadeh, Mona Entezam, Seyed Ali Malek Hosseini, Saman Nikeghbalian, Negar Azarpira, Mahdokht Aghdai, Paria Haddadi, Marjan Rahsaz; Shiraz, Islamic Republic of Iran; Tehran, Islamic Republic of Iran; Shiraz, I

 

LB-P-096               IMPACT OF PHARMACOLOGICAL PRETREATMENT AND ISCHEMIC PRECONDITIONING IN AN ISCHEMIC REPERFUSION INJURY OF THE LIVER

Rauf Shahbazov, Hamdi Karakayali, Sinasi Sevmish, Nihan Haberal, Nilufer Bayraktar, Mehmet Haberal; Baku, Azerbaijan; Ankara, Turkey

 

LB-P-097               COMBINATION THERAPY WITH IBANDRONATE AND CALCITRIOL IS EFFECTIVE IN PATIENTS FOLLOWING LIVER TRANSPLANTATION (LTX): A THREE YEAR PROSPECTIVE CONTROLLED STUDY

Doris Wagner, Hans-Peter Dimai, Karin Amrein, Harald Dobnig, Daniela Kniepeiss, Astrid Fahrleitner; Graz, Austria

 

LB-P-098               INTRAOPERATIVE PLACEMENT OF INFERIOR MESENTERIC VEIN CATHETER: A NOVEL APPROACH FOR PREVENTION OF PORTAL VEIN RETHROMBOSIS IN LIVING DONOR LIVER TRANSPLANTATION

Saman Nikeghbalian, Kourosh Kazemi, Farzad Kakaei, Behnam Sanei, Ali Shamsaeefar, Ali Bahador, Heshmatollah Salahi, Mohammad Aliakbarian, Amin Bahraini, Seyed Ali Malekhosseini; Shiraz, Islamic Republic of Iran; Tabriz, Islamic Republic of Iran; Isfahan,

 

LB-P-099               SMALL BOWEL AUTOTRANSPLANTATION FOR LOCALLY ADVANCED CARCINOMA OF THE PANCREAS

Saman Nikeghbalian, Kourosh Kazemi, Behnam Sanei, Farzad Kakaei, Ali Shamsaeefar, Heshmatollah Salahi, Ali Bahador, Mohammad Aliakbarian, Naser Tutuni, Alireza Ghaffari, Amin Bahraini, Seyed Ali Malekhosseini; Shiraz, Islamic Republic of Iran; tabriz, Isl

 

LB-P-100               LDLT USING A GRAFT FROM A DONOR WITH SITUS INVERSUS TOTALIS

Ki-Hun Kim, Deok-Bok Moon, Tae-Yong Ha, Dong-Hwan Jung, Sam-Youl Yoon, Yo-Han Park, Hyung-Woo Park, Hyo-Jun Lee, Sung-Gyu Lee; Seoul, Republic of Korea

 

LB-P-101               IS MICROSURGICAL TECHNIQUE USEFUL IN BILIARY RECONSTRUCTION OF LIVING DONOR LIVER TRANSPLANTATION?

                                Young Seok Han, Joo Dong Kim, Dong Lak Choi; Daegu, Republic of Korea

 

LB-P-102               CLINICAL CONSEQUENCE OF HEPATIC PARENCHYMAL INFARCT OF NON-VASCULAR ORIGIN FOLLOWING LIVER TRANSPLANTATION

                                Samyoul Yoon, SungGyu Lee; Seoul, Korea

 

LB-P-103               CHANGES IN CORE TEMPERATURE DURING GRAFT WARM ISCHEMIA AND REPERFUSION PHASES IN LIVING DONOR LIVER TRANSPLANT

                                Mahammed H. Abdullah, Ibrahim A. Salama, Wassam S. Morad; Shiben ELkom, Egypt

 

LB-P-104               RIGHT POSTERIOR PORTAL VEIN STENOSIS DEVELOPED AFTER LIVING DONOR LIVER TRANSPLANTATION USING A MODIFIED RIGHT LOBE GRAFT WITH A TYPE 2 PORTAL VEIN

                                Youngdong Yu, Dongsik Kim, Geonyoung Byun, Sungock Suh; Seoul, Korea

 

LB-P-105               LIVER ABSCESS DEVELOPED AFTER CADAVERIC LIVER TRANSPLANTATION DUE TO LIGATION OF A ACCESSORY RIGHT HEPATIC ARTERY OF THE DONOR GRAFT

                                Youngdong Yu, Dongsik Kim, Geonyoung Byun, Sungok Suh; Seoul, Korea

 

LB-P-106               ESOPHAGOGASTRIC VARICES CORRELATE WITH THE DEGREE OF LIVER DISEASE IN LIVER TRANSPLANT RECIPIENTS

Remy Schwarzer, Maximilian Thum, Rastko Karatosic, Ursula Burger-Klepp, Valentin Fuhrmann, Gabriela Berlakovich, Andreas Bacher, Peter Faybik; Vienna, Austria

 

LB-P-107               LIVING DONOR LIVER TRANSPLANTATION FOR TYPE II CITRULLINEMIA IN THE KOREAN PATIENT

                                Minyoung Jung, SungGyu Lee; Seoul, Korea

 

LB-P-108               BENEFITS OF EARLY ENTERAL NUTRITION AFTER LIVER TRANSPLANT SURGERY

                                Ik Jin Yun; Seoul, Korea

 

LB-P-109               EARLY CLINICAL EXPERIANCE OF LUNG TRANSPLANTATION AFTER EX-VIVO LUNG PERFUSION

Andreas Wallinder, Sven-Erik Ricksten, Gerdt Riise, Christoffer Hansson, Martin Silverborn, Hans Liden, Göran Dellgren; Gothenburg, Sweden

 

LB-P-110               SINGLE CENTER EXPERIENCE OF PANCREAS TRANSPLANTATION

Jae Berm Park, Young Hoon Kim, Young Soo Chung, Joong-Yeol Park, Song-Cheol Kim, Duck Jong Han; Seoul, Republic of Korea

 

LB-P-111               SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION IN PATIENTS WITH TYPE 2 DIABETIC END-STAGE RENAL DISEASE

Young Hoon Kim, Jae Berm Park, Young Soo Chung, Ki Byung Song, Song-Cheol Kim, Duck Jong Han; Seoul, Republic of Korea

 

LB-P-112               A NOVEL TECHNIQUE OF COMBINED EN-BLOC PANCREAS KIDNEY TRANSPLANTATION

Saman Nikeghbalian, Farzad Kakaei, Ali Shamsaeefar, Behnam Sanei, Mehdi Salehipour, Seyed Ali Malekhosseini, Farzad Kakaei; Shiraz, Islamic Republic of Iran; Tabriz, Islamic Republic of Iran; Isfahan, Islamic Republic of Iran

 

LB-P-113               PERIOPERATIVE TRANSFUSION REQUIREMENTS AND GRAFT SURVIVAL IN PATIENTS WITH PANCREAS RETRANSPLANTATION [ndash] A RETROSPECTIVE STUDY

                                Jan M. Fertmann, Karl-Walter Jauch, Johannes N. Hoffmann; Munich, Germany

 

LB-P-114               PEDIATRIC LIVER TRANSPLANTATION USING GRAFTS FROM DONORS AFTER CARDIAC DEATH: A FEASIBLE OPTION WITH EXCELLENT RESULTS

Diego Davila, Ruben Ciria, Wayel Jassem, Anil Dhawan, Hector Vilca-Melendez, Mohamed Rela, Nigel Heaton; London, United Kingdom

 

LB-P-115               PEDIATRIC EXPERIENCE FOR THE USE OF SIROLIMUS IN RENAL TRANSPLANTATION PATIENT WITH CALCINEURIN INHIBITOR (CNI) TOXICITY

                                Pak Chiu Tong, Wai Ming Lai, Lap Tak Ma, Kei Chiu Tse, Man Chun Chiu; Hong Kong, China

 

LB-P-116               PREDICTORS OF EARLY GRAFT SURVIVAL IN PEDIATRIC LIVER TRANSPLANTATION

Ruben Ciria, Diego Davila, Shirin Khorsandi, Anil Dhawan, Hector Vilca-Melendez, Mohamed Rela, Nigel Heaton; London, United Kingdom

 

LB-P-117               BILIARY COMPLICATIONS IN PEDIATRIC LIVER TRANSPLANTATION: A 18 YEAR SINGLE CENTER EXPERIENCE IN 429 CASES

Jairo Rivera, Tom Darius, Fabio Fusaro, Catherine de Magnée, Olga Ciccarelli, Jan Lerut, Magda Janssen, Raymond Reding; Brussels, Belgium; Bogota, Colombia

 

LB-P-118               NOVEL HISTOLOGICAL SCORING SYSTEM FOR LONG-TERM ALLOGRAFT FIBROSIS AFTER LIVER TRANSPLANTATION IN CHILDREN

Carla Venturi, Christine Sempoux, Joan Carles Ferreres Pinas, Jorge Abarca Quinones, Isabelle Leclercq, Jacques Rahier, Raymond Reding; Brussels, Belgium; Barcelona, Spain; Brussels, Belgium

 

LB-P-119               [bold]PEDIATRIC ORGAN DONORS AND RECIPIENTS: FACTS AND POTENTIALS[/bold]

Günter Kirste, Thomas Breidenbach; Erlangen, Germany; Frankfurt, Germany; München, Germany

 

LB-P-120               ONLINE RAPID SAMPLING MICRODIALYSIS (rsMD) FOR VIABILITY ASSESSMENT, COMPARING STATIC COLD STORAGE VERSUS HYPOTHERMIC MACHINE PERFUSION IN MARGINAL ALLOGRAFTS

Samir Damji, Karim Hamaoui, Nick Bullock, Martyn Boutelle, Leong Agnes, Michelle Rogers, Sally Gowers, George Hanna, Ara Darzi, Vasilios Papalois; London, United Kingdom

 

LB-P-121               HIGH INCIDENCE OF DELAYED RENAL GRAFT FUNCTION AFTER PROLONGED COLD ISCHEMIA ASSOCIATES WITH 4G/4G PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) GENE POLYMORPHISM

                                Vladimir Abramov, Vera Morozova, Jan Moisiuk; Moscow, Russian Federation

 

LB-P-122               PRETREATMENT WITH MANGAFODIPIR IMPROVES LIVER GRAFT TOLERANCE TO ISCHEMIA/REPERFUSION INJURY

Yann Mouchel, Ismail Ben Mosbah, Anne Crolu, Fabrice Morel, Karim Boudjema, Philippe Compagnon; Rennes, France

 

LB-P-123               A CHEMICAL CHAPERONE INHIBITS ENDOPLASMIC RETICULUM STRESS AND PROTECTS STEATOTIC AND NON-STEATOTIC LIVERS IN PARTIAL HEPATECTOMY UNDER ISCHEMIA-REPERFUSION

Ismail Ben Mosbah, Cecile Martel, Mohamed Amine Zouali, Catherine Brenner, Joan Rosello Catafau; Barcelona, Spain; Rennes, France; Châtenay Malabry, France

 

LB-P-124               PORCINE ENDOGENOUS RETROVIRUS (PERV) INTEGRATION IN THE PIG GENOME

Linda Scobie, Rashmi Wali, Chris Bauser, Claire Rogel-Galliard, Jonas Blomberg, Goran Sperber, Yasu Takeuchi; Glasgow, United Kingdom; Konstanz, Germany; Jouy-en-Josas, France; Uppsala, Sweden; London, United Kingdom

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

               

 


 
cta